Unico American (UNAM) 10-K 31 Mar 21 2020 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 30, 2021	Jun. 30, 2020
Document And Entity Information
Entity Registrant Name	UNICO AMERICAN CORP
Entity File Number	000-03978
Entity Central Index Key	0000100716
Document Type	10-K
Document Period End Date	Dec. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Is Entity Small Business?	true
Is Entity an Emerging Growth Company?	false
Is Entity a Shell Company?	false
Entity Public Float			$ 15,026,506
Entity Common Stock, Shares Outstanding		5,304,885
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2020
Entity Incorporation State Country Code	NV

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Available-for-sale:
Fixed maturities, at fair value (amortized cost: $80,071,280 at December 31, 2020, and amortized cost: $82,002,411 at December 31, 2019)	$ 83,409,694	$ 83,499,710
Held-to-maturity:
Fixed maturities, at amortized cost (fair value: $798,000 at December 31, 2020, and fair value: $798,000 at December 31, 2019)	798,000	798,000
Equity securities, at fair value (cost: $2,548,440 at December 31, 2020, and cost: $0 at December 31, 2019)	2,746,706	0
Short-term investments, at fair value	200,000	2,196,815
Total Investments	87,154,400	86,494,525
Cash and cash equivalents	3,957,980	5,781,639
Accrued investment income	402,046	397,302
Receivables, net	3,321,337	4,019,437
Reinsurance Recoverable:
Paid losses and loss adjustment expenses	621,307	685,841
Unpaid losses and loss adjustment expenses	22,253,642	14,725,855
Deferred policy acquisition costs	3,503,248	3,619,594
Real estate held for sale	8,335,017	0
Property and equipment (net)	2,038,415	10,226,595
Deferred income taxes	0	3,925,432
Other assets	313,363	430,305
Total Assets	131,900,755	130,306,525
LIABILITIES
Unpaid losses and loss adjustment expenses	74,893,509	55,066,480
Unearned premium	18,188,298	17,810,337
Advance premium and premium deposits	208,538	219,083
Accrued expenses and other liabilities	3,577,450	2,130,300
Total Liabilities	96,867,795	75,226,200
STOCKHOLDERS' EQUITY
Common stock, no par, authorized 10,000,000 shares; issued and outstanding shares 5,304,885 at December 31, 2020, and 5,306,720 at December 31, 2019	3,771,767	3,772,669
Accumulated other comprehensive loss	2,637,347	1,182,866
Retained earnings	28,623,846	50,124,790
Total Stockholders Equity	35,032,960	55,080,325
Total Liabilities and Stockholders' Equity	$ 131,900,755	$ 130,306,525

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Consolidated Balance Sheets Parenthetical Abstract
Fixed maturities, available for sale, amortized cost	$ 80,071,280	$ 82,002,411
Fixed maturities, held to maturity, fair value	798,000	798,000
Equity securities, cost	$ 2,548,440	$ 0
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	5,304,885	5,306,720
Common stock, shares outstanding	5,304,885	5,306,720

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
REVENUES
Net premium earned	$ 28,168,168	$ 26,737,468
Investment income	1,988,243	2,097,942
Net realized investments gains (losses)	97,771	(12,661)
Net unrealized investments gains on equity securities	198,266	0
Other income	32,713	123,050
Total Insurance Company Operation	30,485,161	28,945,799
Other Insurance Operations
Gross commissions and fees	1,827,263	2,176,658
Finance fees earned	240,589	239,524
Other income	7,098	10,833
Total Revenues	32,560,111	31,372,814
EXPENSES
Losses and loss adjustment expenses	34,642,920	22,576,127
Policy acquisition costs	4,898,807	4,960,846
Salaries and employee benefits	6,364,170	4,067,852
Commissions to agents/brokers	95,315	173,796
Other operating expenses	4,502,414	2,844,083
Total Expenses	50,503,626	34,622,704
Loss before income taxes	(17,943,515)	(3,249,890)
Income tax expense (benefit)	3,547,598	(134,187)
Net Loss	$ (21,491,113)	$ (3,115,703)
Basic
Loss per share	$ (4.05)	$ (0.59)
Weighted average shares	5,305,829	5,306,879
Diluted
Loss per share	$ (4.05)	$ (0.59)
Weighted average shares	5,305,829	5,306,879

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Consolidated Statements Of Comprehensive Income
Net loss	$ (21,491,113)	$ (3,115,703)
Other changes in comprehensive income (loss), net of tax:
Changes in unrealized gains on securities classified as available-for-sale arising during the period, net of income tax	1,454,481	2,282,902
Comprehensive Loss	$ (20,036,632)	$ (832,801)

Shareholders Equity

Shareholders Equity - USD ($)	Common Stock	Comprehensive Income / Loss	Retained Earnings / Accumulated Deficit	Total
Beginning Balance, Value at Dec. 31, 2018	$ 3,772,857	$ (1,100,036)	$ 53,242,601	$ 55,915,422
Beginning Balance, Shares at Dec. 31, 2018	5,307,103
Shares Repurchased, Value	$ 188		2,108	$ 2,296
Shares Repurchased, Shares	383			383
Change in Comprehensive Income, net of Deferred Income Tax		2,282,902		$ 2,282,902
Net Loss			(3,115,703)	(3,115,703)
Ending Balance, Value at Dec. 31, 2019	$ 3,772,669	1,182,866	50,124,790	55,080,325
Ending Balance, Shares at Dec. 31, 2019	5,306,720
Shares Repurchased, Value	$ 902		9,831	$ 10,733
Shares Repurchased, Shares	1,835			1,835
Change in Comprehensive Income, net of Deferred Income Tax		1,454,481		$ 1,454,481
Net Loss			(21,491,113)	(21,491,113)
Ending Balance, Value at Dec. 31, 2020	$ 3,771,767	$ 2,637,347	$ 28,623,846	$ 35,032,960
Ending Balance, Shares at Dec. 31, 2020	5,304,885

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash Flows from Operating Activities:
Net Loss	$ (21,491,113)	$ (3,115,703)
Adjustments to reconcile net income (loss) to net cash from operations
Depreciation and amortization, gross of asset retirement	673,895	565,876
Bond amortization, net	33,072	(19,874)
Net realized investment losses (gains)	(97,771)	12,661
Net unrealized investment gains on equity securities	(198,266)	0
Bad debt expense	6,451	7,881
Net receivables and accrued investment income	686,905	(97,770)
Reinsurance recoverable	(7,463,253)	(5,881,413)
Deferred policy acquisition costs	116,346	(129,866)
Other assets	116,942	127,138
Unpaid losses and loss adjustment expenses	19,827,029	3,409,325
Unearned premium	377,961	1,845,748
Advance premium and premium deposits	(10,545)	(15,359)
Accrued expenses and other liabilities	1,447,150	284,942
Income taxes current/deferred	3,538,798	(156,796)
Net Cash Used by Operating Activities	(2,436,399)	(3,163,210)
Cash Flows from Investing Activities
Purchase of fixed maturity investments	(20,580,448)	(10,975,077)
Purchase of equity securities	(2,548,440)	0
Proceeds from maturity of fixed maturity investments	16,050,870	10,137,673
Proceeds from sale or call of fixed maturity investments	6,525,408	3,472,794
Net decrease in short-term investments	1,996,815	2,494,139
Additions to property and equipment	(820,732)	(1,100,146)
Net Cash Provided Investing Activities	623,473	4,029,383
Cash Flows from Financing Activities
Repurchase of common stock	(10,733)	(2,296)
Net Cash Used by Financing Activities	(10,733)	(2,296)
Net increase (decrease) in cash and cash equivalents	(1,823,659)	863,877
Cash and cash equivalents at beginning of period	5,781,639	4,917,762
Cash and Cash Equivalents at End of Period	3,957,980	5,781,639
Cash paid during the period for:
Income taxes	$ 8,800	$ 8,800

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Summary of Significant Accounting Policies	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Business Unico American Corporation (the “Company” or “Unico”) is an insurance holding company that underwrites property and casualty insurance through its insurance company subsidiary; provides property, casualty, and health insurance through its agency subsidiaries; and provides insurance premium financing and membership association services through its other subsidiaries. References to Unico or the Company include both the corporation and its subsidiaries, all of which are wholly owned. Unico was incorporated under the laws of Nevada in 1969. Principles of Consolidation The accompanying consolidated financial statements include the accounts of Unico American Corporation and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Basis of Presentation The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”). As described in Note 14, the Company's insurance subsidiary also files financial statements with regulatory agencies prepared on a statutory basis of accounting that differs from GAAP. Certain reclassifications have been made to prior period amounts to conform to the current year’s presentation. Use of Estimates in the Preparation of the Financial Statements The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect its reported amounts of assets and liabilities and its disclosure of any contingent assets and liabilities at the date of its financial statements, as well as its reported amounts of revenues and expenses during the reporting period. The most significant assumptions in the preparation of these consolidated financial statements relate to losses and loss adjustment expenses. While every effort is made to ensure the integrity of such estimates, actual results may differ. Investments The Company’s fixed maturity investments are classified either as held-to-maturity or available-for-sale and are stated at fair value. Although part of the Company's investments is classified as available-for-sale and the Company may sell investment securities from time to time in response to economic and market conditions, , its investment guidelines fair value. The unrealized gains or losses net of any deferred tax effect. When a decline in the value of a fixed maturity is The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income security whose carrying value may be other-than-temporarily impaired. For each fixed income security in an unrealized loss position, the Company assesses whether it is more likely than not that the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes, or the credit quality of the underlying security. If a security meets this criteria, the security's decline in fair value is considered other than temporary and is recorded as a net realized investment loss in the Consolidated Statements of Operations and in the Consolidated Statements of Comprehensive Income (Loss) based on the specific identification method. There were no realized investments gains (losses) from other than temporary impairments for any of the periods presented in the accompanying Consolidated Statements of Operations. For each fixed income security that the Company does not intend to sell or for which it is more likely than not that the Company would not be required to sell before an anticipated recovery in value, the Company separates the credit loss component of the impairment, if any, from the amount related to all other factors and reports the credit loss component in net realized investment gains (losses). There was no credit loss component for any of the periods presented in the accompanying Consolidated Statements of Operations. The short-term investments include U.S. Treasury bills, certificates of deposit, and commercial paper that are all highly rated and have initial maturity between three and twelve months. Fair Value of Financial Instruments The Company employs a fair value hierarchy that prioritizes the inputs for valuation techniques used to measure fair value. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price). Financial assets and financial liabilities recorded on the Consolidated Balance Sheets at fair value are categorized based on the reliability of inputs to the valuation techniques. (See Note 5.) The Company has used the following methods and assumptions in estimating its fair value disclosures for instruments carried at fair value: Available-for-sale fixed securities, equity securities, and short-term investments – Fair values are obtained from widely accepted third party vendors. The Company has used the following methods and assumptions for estimating fair value for other financial instruments not carried at fair value: Cash and cash equivalents – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. Long-term certificates of deposit – The carrying amounts reported in the Consolidated Balance Sheets for these instruments are at amortized cost which approximates their fair value Receivables, net – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. Accrued expenses and other liabilities – The carrying amounts reported in the Consolidated Balance Sheets approximate the fair values given the short-term nature of these instruments. Property and Equipment All property and equipment held for use is stated at cost less accumulated depreciation and amortization on the Consolidated Balance Sheets. Depreciation on building, is computed using the straight-line method over 39 years. Improvements to the building structure are amortized over the useful life of the improvements. Depreciation on computed using the straight-line method over 3 to 15 years. Amortization of tenant improvements in the Calabasas building was being computed using the shorter of the useful life of the tenant improvements or the remaining years of the lease. Income Taxes The Company and its subsidiaries file consolidated federal and state income tax returns. Pursuant to the tax allocation agreement, Crusader and American Acceptance Corporation (“AAC”), a subsidiary of Unico, are allocated taxes or tax credits in the case of losses, at current corporate rates based on their own taxable income or loss. The Company files income tax returns under U.S. federal and various state jurisdictions. The Company is subject to examination by U.S. federal income tax authorities for tax returns filed starting at taxable year 2017 and California state income tax authorities for tax returns filed starting at taxable year 2016. There are no ongoing examinations of income tax returns by federal or state tax authorities. As a California insurance company, Crusader is obligated to pay a premium tax on direct written premium in all states that Crusader is admitted. Premium taxes are deferred and amortized as the related premium is earned. The premium tax is in lieu of state franchise taxes and is not included in the provision for state taxes. The provision for federal income taxes is computed on the basis of income as reported for financial reporting purposes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and are measured using the enacted tax rates and laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Income tax expense provisions increase or decrease in the same period in which a change in tax rates is enacted. At each balance sheet date, management assesses the need to establish a valuation allowance that reduces deferred tax assets when it is more-likely-than-not that any portion of the deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon generating sufficient taxable income of the appropriate character within the carryback and carryforward periods available under the tax law. Management considers the reversal of deferred tax liabilities, projected future taxable income of an appropriate nature and tax-planning strategies when making this assessment. In connection with preparation of its consolidated financial statements, the Company periodically performs an analysis of future income projections to determine the adequacy of the valuation allowance. In light of the net losses that were generated in recent years, for the twelve months ended December 31, 2020, the Company has established a valuation allowance for the aggregate amount of the federal and state net operating losses and other deferred tax assets in the amount of $10,557,080 that, in management’s judgment, are not more-likely-than-not to be realized. For the year ended December 31, 2019, the Company carried a valuation allowance on deferred tax assets generated from federal and state net operating losses in the amount of $600,000 and $1,931,665, respectively. Earnings Per Share Basic earnings per share exclude the impact of common share equivalents and are based upon the weighted average common shares outstanding. Diluted earnings per share utilize the average market price per share when applying the treasury stock method in determining common share dilution. When outstanding stock options are dilutive, they are treated as common share equivalents for purposes of computing diluted earnings per share and represent the difference between basic and diluted weighted average shares outstanding. In loss periods, the options are excluded from the calculation of diluted earnings per share, as the inclusion of such options would have an anti-dilutive effect. Revenue Recognition a. General Agency Operations Commissions from sales of health insurance are earned in income based on the satisfaction of a single performance obligation. Marketing, selling, billing, collecting, and administering health insurance policies are a series of distinct services combined as a one performance obligation, which is recognized in income monthly over the policy period. Premiums are collected upon the initial sale of health insurance policies and then monthly upon each subsequent periodic payment. As a result there are limited accounts receivable. Policy fee income is recognized on a pro-rata basis over the terms of the policies. b. Insurance Company Operation Premium is earned on a pro-rata basis over the terms of the policies. Premium applicable to the unexpired terms of policies in force are recorded as unearned premium. c. Insurance Premium Financing Operations Premium finance interest may be charged to policyholders who choose to finance insurance premium. Interest may be charged at rates that vary with the amount of premium financed. Premium finance interest, if any, is recognized using a method that approximates the interest (actuarial) method. Other charges and fees earned include late fees, returned check fees and payment processing fees that are earned when recorded. Losses and Loss Adjustment Expenses The liability for unpaid losses and loss adjustment expenses is based upon the accumulation of individual case estimates for losses reported prior to the close of the accounting period plus estimates based on experience and industry data for development of case estimates and for incurred but unreported losses and loss adjustment expenses. There is a high level of uncertainty inherent in the evaluation of the required loss and loss adjustment expense reserves for Crusader. The long-tailed nature of liability claims and the volatility of jury awards exacerbate that uncertainty. Crusader records The ultimate cost of claims is dependent upon future events, the outcomes of which are affected by many factors. Crusader’s claim reserving procedures and settlement philosophy, current and perceived social and economic inflation, current and future court rulings and jury attitudes, improvements in medical technology, and many other economic, scientific, legal, political, and social factors all can have significant effects on the ultimate costs of claims. Changes in Company operations and management philosophy also may cause actual developments to vary from the past. Since the emergence and disposition of claims are subject to uncertainties, the net amounts that will ultimately be paid to settle claims may vary significantly from the estimated amounts provided for in the accompanying consolidated financial statements. Any adjustments to reserves are reflected in the operating results of the periods in which they are made. Management believes that the aggregate reserves for losses and loss adjustment expenses are reasonable and adequate to cover the cost of claims, both reported and unreported. The Company applies judgment in determining estimates for reserves associated with anticipated recoveries of salvage and subrogation on paid losses and loss adjustment expenses. During the year ended December 31, 2019, the Company changed that estimate to be in-line with its historic salvage and subrogation recovery success pattern. The impact of that change was a $968,400 reduction in losses and loss adjustment expenses for the year ended December 31, 2019, and in unpaid losses and loss adjustment expenses. The change was accounted for as a change in accounting estimate. Restricted Funds Restricted funds are as follows: Year ended December 31 2020 2019 Premium trust funds (1) $ 1,595,135 $ 1,758,915 Assigned to state agencies (2) 710,000 710,000 Funds held as collateral (3) 787,653 — Total restricted funds $ 3,092,788 $ 2,468,915 (1) As required by law, the Company segregates from its operating accounts the premium collected from insureds that are payable to insurance companies into separate trust accounts. (2) $510,000 included in fixed maturity investments as of December 31, 2020 and 2019, and $200,000 included in short-term investments as of December 31, 2020 and 2019, are statutory deposits assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in states other than California. (3) Funds held as collateral by Comerica Bank & Trust, N. A. (“Comerica”) included in available-for-sale fixed maturities pursuant to the reinsurance trust agreement among Crusader, United Specialty Insurance Company (“USIC”) and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. Deferred Policy Acquisition Costs Policy acquisition costs consist of commissions, premium taxes, inspection fees, and certain other underwriting costs, which are related to the successful production of Crusader insurance policies. Policy acquisition costs that are eligible for deferral are deferred and amortized as the related premium is earned and are limited to their estimated realizable value Ceding commission applicable to the unexpired terms Reinsurance Crusader employs reinsurance to provide greater diversification of business allowing management to control exposure to potential losses arising from large risks by reinsuring certain levels of risk in various areas of exposure, to reduce the loss that may arise from catastrophes, and to provide additional capacity for growth. Prepaid reinsurance premium and reinsurance receivables are reported as assets and represent ceded unearned premium and reinsurance recoverable on both paid and unpaid losses and loss adjustment expenses, respectively. Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liability associated with the reinsured policies. Crusader evaluates each of its ceded reinsurance contracts at its inception to determine if there is sufficient risk transfer to allow the contract to be accounted for as reinsurance under current accounting literature. As of December 31, 2020, all such ceded contracts are accounted for as risk transfer reinsurance. Crusader evaluates and monitors the financial condition of its reinsurers and factors such as collection periods, disputes, applicable coverage defenses and other factors to assess the need for any allowance against anticipated reinsurance recoveries. No such allowance was considered necessary at December 31, 2020 or 2019. Concentration of Risks 99.9% of Crusader’s gross written premium was derived from California during the years ended December 31, 2020 and 2019. In 2020, approximately 30% and 56% of the $727,515 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. In 2019, approximately 39% and 49% of the $939,689 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. Crusader’s reinsurance recoverable on paid and unpaid losses and loss adjustment expenses is as follows: Year ended December 31 Name of Reinsurer A.M. Best Rating (1) 2020 2019 Renaissance Reinsurance U.S. Inc. A+ $ 11,906,416 $ 8,095,647 Hannover Ruck SE A+ 10,673,173 6,869,914 TOA Reinsurance Company of America A 295,188 438,308 Other A 172 7,827 Total $ 22,874,949 $ 15,411,696 (1) A.M. Best ratings are as of December 31, 2020. Stock-Based Compensation Share-based compensation expense for all share-based payment awards is based on the grant-date fair value estimated in accordance with the provisions of ASC Topic 718, “Compensation - Stock Compensation” using the modified prospective transition method. Recently Issued Accounting Standards Recently adopted standards In February 2016, the FASB issued ASU 2016-02 “Leases.” ASU 2016-02 requires lessees to recognize on the balance sheet the assets and liabilities for the rights and obligations created by all leases, including those historically accounted for as operating leases. The Company adopted ASU 2016-02 effective January 1, 2019. The adoption of ASU 2016-02 did not have a material impact to the Consolidated Statements of Operations and the Consolidated Balance Sheets. In August, 2018, the FASB issued ASU 2018-13 “Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 modifies the disclosure requirements for assets and liabilities measured at fair value. The amendments in this ASU require certain existing disclosure requirements to be modified or removed, and certain new disclosure requirements to be added. In addition, this ASU allows entities to exercise more discretion when considering fair value measurement disclosures. This ASU is effective for annual and interim reporting periods beginning after December 15, 2019. The Company adopted ASU 2018-13 effective January 1, 2020. The adoption of ASU 2018-13 did not have a material impact to the Company’s disclosures. Standards not yet adopted In June 2016, the FASB issued ASU 2016-13 “Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 replaces the current incurred loss methodology for recognizing credit losses with a current expected credit loss model, which requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 also requires enhanced disclosures for better understanding of significant estimates and judgments used in estimating credit losses. The Company is currently evaluating the effect ASU 2016-13 will have on the Company's consolidated financial statements, but expects the primary changes to be (i) the use of the expected credit loss model for its premium receivables and reinsurance recoverables and (ii) the presentation of credit losses within the available-for-sale fixed maturities portfolio through an allowance method rather than as a direct write-down. ASU 2016-13 will primarily impact the Company’s available-for-sale fixed maturities portfolio and reinsurance recoverables. In November 2019, the FASB issued ASU 2019-10 “Financial Instruments – Credit Losses, Derivatives and Hedging, and Leases.” ASU 2019-10 updated the effective date for implementing ASU 2016-13 for smaller reporting entities, and that effective date will be for fiscal years beginning after December 15, 2022. Since the Company’s fixed income portfolio is invested primarily in higher rated bonds and the reinsurance is purchased from financially strong reinsurers, the Company believes the adoption of ASU 2016-13 will not have a material impact to the Consolidated Statements of Operations and the Consolidated Balance Sheets. In December of 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes or ASU 2019-12. ASU 2019-12 is expected to reduce the cost and complexity related to the accounting for income taxes. The ASU removes specific exceptions to the general principles in Topic 740 and improves the financial statement preparer's application of income tax related guidance. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.

Cash and Cash Equivalents

Cash and Cash Equivalents	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Cash and Cash Equivalents	NOTE 2 – CASH AND CASH EQUIVALENTS The following table provides a reconciliation of cash and cash equivalents reported within the Consolidated Balance Sheets to the amounts shown in the Consolidated Statements of Cash Flows: 2020 2019 Cash $ 3,383,048 $ 2,490,902 Cash equivalents 574,932 3,290,737 Cash and cash equivalents $ 3,957,980 $ 5,781,639 Cash equivalents were comprised of highly liquid investments with initial maturity of 90 days or less. As of December 31, 2020 and 2019, cash equivalents included custodial trust, bank money market accounts, and a bank savings account.

Advance Premium and Premium Dep

Advance Premium and Premium Deposits	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Advance Premium And Premium Deposits	NOTE 3 – ADVANCE PREMIUM AND PREMIUM DEPOSITS The insurance company operation records an advance premium liability that represents the deposits on written premium on policies that have been submitted to the Company and are bound, billed, and recorded prior to their effective date of coverage. The advance premium is not included in written premium or in the liability for unearned premium. Some of the Company’s health and life programs require payments of premium prior to the effective date of coverage; and, accordingly, invoices are sent out as early as two months prior to the coverage effective date. Insurance premium received for coverage months effective after the

Investments

Investments	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Investments	NOTE 4 – INVESTMENTS A summary of investment income, net of investment expenses, net realized gains, and net unrealized investment gains on equity securities is as follows: Year ended December 31 2020 2019 Fixed maturities $ 2,068,592 $ 2,162,142 Equities 28,727 — Short-term investments and cash equivalents 24,603 65,642 Gross investment income 2,121,922 2,227,784 Less investment expenses (133,679 ) (129,842 ) Net investment income 1,988,243 2,097,942 Net realized gains (losses) 97,771 (12,661 ) Net unrealized gains on equity securities 198,266 — Net investment income, realized gains (losses) and unrealized gains $ 2,284,280 $ 2,085,281 The amortized cost and estimated fair value of fixed maturity investments at December 31, 2020, by contractual maturity are as follows: Amortized Cost Estimated Fair Value Due in one year or less $ 11,064,202 $ 11,169,232 Due after one year through five years 30,090,910 31,260,694 Due after five years through ten years 18,476,051 19,806,444 Due after ten years and beyond 21,238,117 21,971,324 Total fixed maturities $ 80,869,280 $ 84,207,694 Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties. The amortized cost and estimated fair values of investments in fixed maturities by category are as follows: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value December 31, 2020 Available-for-sale fixed maturities: U.S. Treasury securities $ 10,596,808 $ 235,373 $ — $ 10,832,181 Corporate securities 44,159,926 2,347,826 (55,847 ) 46,451,905 Agency mortgage-backed securities 25,314,546 833,336 (22,274 ) 26,125,608 Held-to-maturity fixed maturities: Certificates of deposit 798,000 — — 798,000 Total fixed maturities $ 80,869,280 $ 3,416,535 $ (78,121 ) $ 84,207,694 December 31, 2019 Available-for-sale fixed maturities: U.S. Treasury securities $ 15,105,795 $ 130,564 $ (1,027 ) $ 15,235,332 Corporate securities 41,953,378 1,076,012 (57 ) 43,029,333 Agency mortgage-backed securities 24,943,238 293,757 (1,950 ) 25,235,045 Held-to-maturity fixed maturities: Certificates of deposit 798,000 — — 798,000 Total fixed maturities $ 82,800,411 $ 1,500,333 $ (3,034 ) $ 84,297,710 As of December 31, 2020, one corporate security, included in available-for-sale fixed maturities, was held as collateral with Comerica, pursuant to the reinsurance trust agreement among Crusader, USIC and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. The estimated fair value and amortized cost of that security was $824,500 and $787,653 on December 31, 2020, respectively. A summary of the unrealized gains (losses) on investments carried at fair value and the applicable deferred federal income taxes is as follows: Year ended December 31 2020 2019 Gross unrealized gains of fixed maturities $ 3,416,535 $ 1,500,333 Gross unrealized losses of fixed maturities (78,121 ) (3,034 ) Net unrealized gains on investments 3,338,414 1,497,299 Deferred federal tax expense (701,067 ) (314,433 ) Net unrealized gains, net of deferred income taxes $ 2,637,347 $ 1,182,866 A summary of estimated fair value and gross unrealized losses in a gross unrealized loss position by the length of time in which the securities have continually been in that position is shown below: Less than 12 Months 12 Months or Longer Estimated Gross Unrealized Number of Securities Estimated Gross Unrealized Number of Securities December 31, 2020 U.S. Treasury securities $ — $ — — $ — $ — — Corporate securities 2,101,986 (55,847 ) 2 — — — Agency mortgage-backed securities 3,223,329 (22,274 ) 12 — — — Total debt securities 5,325,315 (78,121 ) 14 — — — Equity securities 723,346 (37,357 ) 25 — — — Total $ 6,048,661 $ (115,478 ) 39 $ — $ — — Less than 12 Months 12 Months or Longer Estimated Fair Value Gross Unrealized Losses Number of Securities Estimated Fair Value Gross Unrealized Losses Number of Securities December 31, 2019 U.S. Treasury securities $ 1,996,562 $ (253 ) 1 $ 1,002,031 $ (775 ) 1 Corporate securities 999,818 (56 ) 1 — — — Agency mortgage-backed securities 750,058 (1,950 ) 2 — — — Total $ 3,746,438 $ (2,259 ) 4 $ 1,002,031 $ (775 ) 1 The Company monitors its investments closely. If an unrealized loss is determined to be other-than-temporary, it is written off as a realized loss through the Consolidated Statements of Operations. The Company’s methodology of assessing other-than-temporary impairments is based on security-specific analysis as of the balance sheet date and considers various factors including the length of time to maturity and the extent to which the fair value has been less than the cost, the financial condition and the near-term prospects of the issuer, and whether the debtor is current on its contractually obligated interest and principal payments. The unrealized losses as of December 31, 2020, and December 31, 2019, were determined to be temporary. Although the Company does not intend to sell its fixed maturity investments prior to maturity, the Company may sell investment securities from time to time in response to cash flow requirements, economic and/or market conditions or investment securities may be called by their issuers prior to the securities’ maturity. December 31 December 31 2020 2019 Fixed maturities securities sold Number of securities sold 15 3 Amortized cost of sold securities $ 5,529,470 $ 2,997,098 Realized gains (losses) on sales $ 52,053 $ (12,679 ) Fixed maturities securities called Number of securities called 4 1 Amortized cost of called securities $ 2,449,503 $ 999,982 Realized gains on calls $ 497 $ 18 The unrealized gains or losses from fixed maturities are reported as “Accumulated other comprehensive income or loss,” which is a separate component of stockholders’ equity, net of any deferred tax effect. The Company started investing in common stock equity securities during the year ended December 31, 2020. The Company’s equity securities allocation is intended to enhance the return of and provide diversification for the total investment portfolio. A summary of equity securities is shown below: December 31 December 31 2020 2019 Cost $ 2,548,440 $ — Unrealized gain 198,266 — Fair market value of equity securities $ 2,746,706 $ — The Company’s investment in certificates of deposit included $598,000 of brokered certificates of deposit as of December 31, 2020 and 2019. All of the Company’s certificates of deposit are within the Federal Deposit Insurance Corporation (“FDIC”) insured permissible limits. Due to the nature of the Company’s business, certain bank accounts may exceed FDIC insured permissible limits. The following securities from three different banks represent statutory deposits that are assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in the state of Nevada. Year ended December 31 2020 2019 Certificates of deposit $ 200,000 $ 200,000 Short-term investments 200,000 200,000 Total state held deposits $ 400,000 $ 400,000 Short-term investments have an initial maturity of one year or less and consist of the following: Year ended December 31 2020 2019 U.S. Treasury bills $ — $ 1,996,815 Certificates of deposit 200,000 200,000 Total short-term investments $ 200,000 $ 2,196,815

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Fair Value of Financial Instruments	NOTE 5 – FAIR VALUE OF FINANCIAL INSTRUMENTS In determining the fair value of its financial instruments, the Company employs a fair value hierarchy that prioritizes the inputs for the valuation techniques used to measure fair value. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price). Financial assets and financial liabilities recorded on the Consolidated Balance Sheets at fair value are categorized based on the reliability of inputs for the valuation techniques as follows: Level 1 – Financial assets and financial liabilities whose values are based on unadjusted quoted prices in active markets for identical assets or liabilities as of the reporting date. Level 2 – Financial assets and financial liabilities whose values are based on quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in non-active markets; or valuation models whose inputs are observable, directly or indirectly, for substantially the full term of the asset or liability as of the reporting date. Level 3 – Financial assets and financial liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect the Company’s estimates of the assumptions that market participants would use in valuing the financial assets and financial liabilities as of the reporting date. The hierarchy gives the highest priority to Level 1 inputs and the lowest priority to Level 3 inputs. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the fair value hierarchy level within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. Thus, a Level 3 fair value measurement may include inputs that are observable (Level 1 or Level 2) or unobservable (Level 3). The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. The following table presents information about the Company’s financial instruments and their estimated fair values, which are measured on a recurring basis, allocated among the three levels within the fair value hierarchy as of December 31, 2020 and 2019: Level 1 Level 2 Level 3 Total December 31, 2020 Financial instruments: Available-for-sale fixed maturities: U.S. Treasury securities $ 10,832,181 $ — $ — $ 10,832,181 Corporate securities — 46,451,905 — 46,451,905 Agency mortgage-backed securities — 26,125,608 — 26,125,608 Equity securities 2,746,706 — — 2,746,706 Short-term investments 200,000 — — 200,000 Total financial instruments at fair value $ 13,778,887 $ 72,577,513 $ — $ 86,356,400 December 31, 2019 Financial instruments: Available-for-sale fixed maturities: U.S. Treasury securities $ 15,235,332 $ — $ — $ 15,235,332 Corporate securities — 43,029,333 — 43,029,333 Agency mortgage-backed securities — 25,235,045 — 25,235,045 Short-term investments 2,196,815 — — 2,196,815 Total financial instruments at fair value $ 17,432,147 $ 68,264,378 $ — $ 85,696,525 Fair value measurements are not adjusted for transaction costs. The Company recognizes transfers between levels at either the actual date of the event or a change in circumstances that caused the transfer. The Company did not have any transfers between Levels 1, 2 and 3 of the fair value hierarchy during the years ended December 31, 2020 and 2019. As a result of the spread of the ongoing coronavirus (“COVID-19”) pandemic, economic uncertainties have arisen which are likely to impact the fair value of investments, day to day administration of the business and premium volume. While the Company does not believe it is exposed to substantial risk from coronavirus-related claims under the insurance policies written by Crusader, it is likely that the fair value of its investment portfolio will be adversely affected by the volatility in the capital markets, as well as general economic conditions as a result of the coronavirus and governmental responses to the pandemic. The financial impact of these uncertainties is unknown at this time.

Property and Equipment (Net of

Property and Equipment (Net of Accumulated Depreciation)	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Property and Equipmentr (Net of Accumulated Depreciation)	NOTE 6 – REAL ESTATE HELD FOR SALE, NET AND PROPERTY AND EQUIPMENT, NET Property and equipment consist of the following: Year ended December 31 2020 2019 Real estate held for sale, located in Calabasas, California $ 10,202,676 $ — Accumulated depreciation and amortization (1,867,659 ) — Real estate held for sale, net $ 8,335,017 $ — Building and tenant improvements, located in Calabasas, California — 8,411,541 Furniture, fixtures, equipment 2,191,411 2,110,653 Computer software 467,275 459,899 Accumulated depreciation and amortization (2,423,617 ) (3,617,381 ) Computer software under development 1,803,346 1,074,398 Land located in Calabasas, California — 1,787,485 Property and equipment, net $ 2,038,415 $ 10,226,595 Real estate held for sale, owned by Crusader, includes land, building, and leasehold improvements. On September 29, 2020, the real estate was listed for sale at a price of $12,999,000. Upon the listing, the Company stopped recording the depreciation expense on the Calabasas building and the leasehold improvements in the Calabasas building. On October 23, 2020, Crusader entered into an agreement to sell the building, the leasehold improvements and substantially all existing furniture, fixtures and equipment for a sale price of $12,695,000. The building was sold on February 12, 2021. Through the date of the real estate listing, depreciation on the Calabasas building was computed using the straight line method over 39 years. Depreciation on furniture, fixtures, and equipment in the Calabasas building is computed using the straight line method over 3 to 15 years. Through the date of the real estate listing, amortization of leasehold improvements in the Calabasas building was computed using the shorter of the useful life of the leasehold improvements or the remaining years of the lease. For the years ended December 31, 2020 and 2019, the Calabasas building has generated rental revenue from non-affiliated tenants in the amount of $150,319 and $177,596, and incurred operating expenses in the amount of $677,930 and $669,359, which included depreciation, respectively. These amounts are included in “Other income” from insurance company operation and other operating expenses, respectively, in the Company’s Consolidated Statements of Operations. The total square footage of the Calabasas building is 46,884, including common areas. As of December 31, 2020, 6,942 square feet of the Calabasas building was leased to non-affiliated entities and 7,539 square feet was vacant and available to be leased to non-affiliated entities. The Company capitalizes certain computer software costs purchased from outside vendors for internal use or incurred internally to upgrade the existing systems. These costs also include configuration and customization activities, coding, testing and installation. Training costs and maintenance are expensed as incurred, while upgrade and enhancements are capitalized if it is probable that such expenditure will result in additional functionality. The capitalized costs are not depreciated until the software is placed into production.

Receivables, Net

Receivables, Net	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Premiums, Commissions and Notes Receivable, Net	NOTE 7 – RECEIVABLES, NET Receivables, net, include premium, commissions and notes receivable and are as follows: Year ended December 31 2020 2019 Premium and commission receivable $ 2,476,679 $ 2,178,476 Premium finance notes receivable 2,036,960 3,041,931 Total premium and notes receivable 4,513,639 5,220,407 Allowance for doubtful accounts (1,192,302 ) (1,200,970 ) Receivables, net $ 3,321,337 $ 4,019,437 Premium receivable and premium finance notes receivables are substantially secured by unearned premium and funds held as security for performance. Premium finance notes receivable represents the balance due to AAC, the Company's premium finance subsidiary, from policyholders who elected to finance their premium over a nine-month term. These notes are net of unearned finance charges and credit loss reserves. Bad debt expense was $6,450 and $7,881 for the years ended December 31, 2020 and 2019, respectively.

Unpaid Losses and Loss Adjustme

Unpaid Losses and Loss Adjustment Expenses	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Unpaid Losses and Loss Adjustment Expenses	NOTE 8 – UNPAID LOSSES AND LOSS ADJUSTMENT EXPENSES Crusader’s loss and loss adjustment expense case and incurred but not reported (“IBNR”) reserves are as follows: Year ended December 31 2020 2019 Gross reserves: Case reserves $ 26,363,695 $ 23,663,743 IBNR reserves 48,529,814 31,402,737 Total gross reserves $ 74,893,509 $ 55,066,480 Reserves net of reinsurance: Case reserves $ 21,027,703 $ 18,128,008 IBNR reserves 31,612,164 22,212,617 Total net reserves $ 52,639,867 $ 40,340,625 Reserves for losses and loss adjustment expenses before reinsurance for each of Crusader’s lines of business are as follows: Year ended December 31 Line of Business 2020 2019 CMP $ 73,545,181 98.2 % $ 54,270,633 98.6 % Other liability 1,283,174 1.7 % 776,957 1.4 % Other 65,154 0.1 % 18,890 0.0 % Total $ 74,893,509 100.0 % $ 55,066,480 100.0 % The Company‘s consolidated financial statements include estimated reserves for unpaid losses and related loss adjustment expenses of the insurance company operation. Crusader sets loss and loss adjustment expense reserves at each balance sheet date based upon management’s best estimate of the ultimate payments that it anticipates will be made to settle all losses incurred and all related loss adjustment expenses incurred as of that date for both reported and unreported claims. The following table provides an analysis of the roll forward of Crusader’s loss and loss adjustment expense reserves, including a reconciliation of the ending balance sheet liability for the periods indicated: Year ended December 31 2020 2019 Reserve for unpaid losses and loss adjustment expenses $ 40,340,625 $ 42,125,553 Incurred losses and loss adjustment expenses: Provision for insured events of current year 26,683,872 19,384,942 Provision for incurred events of prior years 7,959,048 3,191,185 Total incurred losses and loss adjustment expenses 34,642,920 22,576,127 Payments: Losses and loss adjustment expenses attributable to 8,285,021 6,210,475 Losses and loss adjustment expenses attributable to 14,058,657 18,150,580 Total payments 22,343,678 24,361,055 Reserve for unpaid losses and loss adjustment expenses at 52,639,867 40,340,625 Reinsurance recoverable on unpaid losses and loss 22,253,642 14,725,855 Reserve for unpaid losses and loss adjustment expenses at $ 74,893,509 $ 55,066,480 The $26,683,872 provision for insured events of current year for the year ended December 31, 2020, was $7,298,930 higher than the $19,384,942 provision for insured events of current year for the year ended December 31, 2019, due primarily to increased IBNR reserves associated with the Apartments & Commercial Buildings and Transportation verticals. The increases in IBNR reserves were due to higher actuarially developed ultimate incurred losses and loss adjustment expenses primarily as a result of elevated expected claims severity. The $7,959,048 adverse development of insured events of prior years for the year ended December 31, 2020, was $4,767,863 higher than the $3,191,185 adverse development of insured events of prior year for the year ended December 31, 2019, due primarily to increases in 2018 and 2019 accident year IBNR reserves associated with the Apartments & Commercial Buildings and Transportation verticals. The increases in IBNR were due to higher actuarially developed ultimate incurred losses and loss adjustment expenses primarily as a result of elevated expected claims severity. At each review period, actual claims costs that emerge are compared with the claims costs that were expected to emerge during that development period. Sometimes the previous claims costs estimates prove to have been too high; sometimes they prove to have been too low. The fluctuation in development of insured events of prior years’ underscores the inherent uncertainty in insurance claims costs, especially for a relatively small insurer, such as Crusader. Management reviews claims costs that appear to be different from the historical claims costs to determine whether those differences are a normal part of the process or an indication that a change in reserve assumptions is appropriate. Management concluded that the differences noted above are differences between actual and expected claims costs that emerge from time to time, particularly in an insurer the size of Crusader. The following table presents loss development information by accident year, including cumulative incurred and paid losses and allocated loss adjustment expenses (“ALAE”), net of reinsurance, as well as cumulative claim frequency and the total of incurred but not reported liabilities plus expected development on reported claims as of December 31, 2020: Accident Year Cumulative Incurred Cumulative Paid Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims Cumulative Number of Reported Claims 2011 $ 19,150,281 $ 19,150,278 $ — 1,020 2012 18,327,346 18,020,565 222 967 2013 22,802,931 22,802,275 2 849 2014 18,048,285 17,806,537 150,672 760 2015 24,495,614 21,502,400 635,716 749 2016 26,337,621 23,326,143 1,565,938 803 2017 25,091,934 18,869,369 3,060,474 807 2018 20,670,880 12,129,118 6,146,217 605 2019 19,182,851 7,603,418 7,134,966 639 2020 24,302,958 6,004,292 12,910,459 699 Total $ 218,410,701 $ 167,214,395 $ 31,604,666 The following table reconciles the above cumulative incurred and paid data to Crusader’s loss and loss adjustment expense reserves: Year ended December 31 2020 2019 Cumulative incurred losses and ALAE $ 218,410,701 $ 203,000,161 Less cumulative paid losses and ALAE (167,214,395 ) (164,132,073 ) Reserve for unpaid losses and ALAE (latest 10 accident years) 51,196,306 38,868,088 Reserves for unpaid losses and ALAE (beyond latest 10 accident 79,703 126,042 Reserves for unpaid unallocated loss adjustment expenses 1,363,858 1,346,495 Reserve for unpaid losses and loss adjustment expenses, 52,639,867 40,340,625 Reinsurance recoverable on unpaid losses and loss adjustment 22,253,642 14,725,855 Reserve for unpaid losses and loss adjustment expenses, $ 74,893,509 $ 55,066,480 Crusader’s liability for unpaid loss and loss adjustment expense reserves consists of case reserves and reserves for IBNR claims. Case reserves are established by claims personnel based on a review of the facts known at the time the claim is reported and are subsequently revised as more information about a claim becomes known. IBNR is estimated using various actuarial methods and techniques and includes (1) reserves for losses and loss adjustment expenses on claims that have occurred but for which claims have not yet been reported to Crusader, and (2) a provision for expected future development on case reserves for information not currently known. At the end of each fiscal quarter, Crusader’s reserves for each accident year (i.e., for all claims occurring within each year) are re-evaluated independently by the Company’s president, the Company’s chief financial officer, and an independent consulting actuary. Generally accepted actuarial methods, including the widely used Bornhuetter-Ferguson and loss development methods, are employed to estimate ultimate claims costs. An actuarial central estimate of the ultimate claims costs and IBNR reserves is ultimately determined by management and tested for reasonableness by the independent consulting actuary. The Company determines the number of reported claims based on the number of loss events. A claim is considered a single loss event, per policy, and it may include multiple claimants and multiple coverages on a single policy. The cumulative number of reported claims is a sum of open claims, closed claims, and claims closed without payment.

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Deferred Policy Acquisition Costs	NOTE 9 – DEFERRED POLICY ACQUISITION COSTS The following table provides an analysis of the roll forward of the Company’s deferred policy acquisition costs: Year ended December 31 2020 2019 Deferred policy acquisition costs at beginning of year $ 3,619,594 $ 3,489,728 Policy acquisition costs deferred during year 4,782,461 5,090,712 Policy acquisition costs amortized during year (4,898,807 ) (4,960,846 ) Deferred policy acquisition costs at end of year $ 3,503,248 $ 3,619,594 Deferred policy acquisition costs consist of commissions (net of ceding commission), premium taxes, inspection fees, and certain other underwriting costs, which are related to and vary with the production of Crusader policies. Policy acquisition costs are deferred and amortized as the related premium is earned. Deferred acquisition costs are reviewed to determine if they are recoverable from future income on insurance policies generated from these costs, including investment income. The Company recognized a premium deficiency of $150,000 as of December 31, 2020. The Company did not carry a premium deficiency reserve as of December 31, 2019.

Acccrued Expenses and Other Lia

Acccrued Expenses and Other Liabilities	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Acccrued Expenses and Other Liabilities	NOTE 10 – ACCRUED EXPENSES AND OTHER LIABILITIES Accrued expenses and other liabilities consist of the following: Year ended December 31 2020 2019 Premium payable $ 393,466 $ 480,078 Unearned policy fee income 454,883 520,064 Retirement plans 145,473 112,827 Accrued salaries and employee benefits 973,504 501,414 Commission payable 869 1,764 Security deposit for Calabasas building sale 380,850 — Other 1,228,405 514,153 Total accrued expenses and other liabilities $ 3,577,450 $ 2,130,300

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Contingencies	NOTE 11 – COMMITMENTS AND CONTINGENCIES Crusader is also subject to regulatory and governmental examinations, requests for information, inquiries, investigations, and threatened legal actions and proceedings by state regulators and others. Crusader receives numerous requests, orders for documents, and information in connection with various aspects of its regulated activities. Regulatory and governmental requests for information, inquires, certain examinations and investigations are routinely handed by Crusader. Crusader may involve outside counsel in regulatory matters depending on the nature of the matter. The Company establishes reserves for lawsuits, regulatory actions and other contingencies for which the Company is able to estimate its potential exposure and believes a loss is probable. For loss contingencies believed to be reasonably possible, the Company discloses the nature of the loss contingency, an estimate of the possible loss, a range of loss, or a statement that such an estimate cannot be made. Likewise, the Company is sometimes named as a cross-defendant in litigation, which is principally concerning the issuance or non-issuance of individual policies . These items are also handled on a he Company vigorously defends itself unless a reasonable settlement appears appropriate.

Reinsurance

Reinsurance	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Reinsurance	NOTE 12 – REINSURANCE A reinsurance transaction occurs when an insurance company transfers (cedes) a portion of its reinsurer fails to meet its obligations, the Company must nonetheless pay its policy obligations. Crusader’s primary excess of loss reinsurance agreements during the years ended December 31, 2020 and 2019 are as follows: Loss Year Reinsurers A.M. Best Rating Retention 2020 Renaissance Reinsurance U.S. Inc. A+ $ 500,000 2019 Renaissance Reinsurance U.S. Inc. A+ $ 500,000 Reinsurance treaties are generally structured in layers, with different negotiated economic terms and retention of participation, or liability, in each layer. In calendar years 2020 and 2019, Crusader retained a participation in its excess of loss reinsurance treaties of 0% in its 1 st nd Crusader also has catastrophe reinsurance treaties from various risks which Crusader insures. st nd On April 1, 2020, Crusader and Unifax Insurance Systems, Inc. (“Unifax”), a subsidiary of the Company, entered into a reinsurance arrangement with United Specialty Insurance Company (“USIC”), pursuant to which USIC would underwrite property and casualty insurance policies by and through Unifax and such policies would be reinsured by Crusader. On September 2, 2020, the Company placed a moratorium on placing any new risks with USIC by Unifax pending negotiations among Crusader, Unifax, and USIC pursuant to the issues raised by the DOI regarding the structure of the reinsurance arrangement and its compliance with the California Insurance Holding Company System Act (the “Insurance Act”). On November 24, 2020, as a result of such negotiations with the DOI, Crusader, Unifax and USIC agreed to rescind certain agreements by and among USIC, Crusader and Unifax. The effect of such rescissions was that the rescinded agreements were deemed never to have existed and no insurance policies were deemed issued, and no premium deemed written, collected or reported with respect to those agreements. Further, on November 24, 2020, the parties entered into various restructured arrangements in order to address the issues raised by the DOI with respect to California insurance laws. In particular, the parties eliminated all intercompany duties so that the arrangement would not require prior approval by the DOI under the Insurance Act. Details of the restructured arrangements with USIC include the following: On November 24, 2020, USIC and Crusader entered into a new Quota Share Reinsurance Agreement, effective April 1, 2020, (the “New Reinsurance Agreement”), pursuant to which Crusader will reinsure all of USIC’s liability for policies issued by USIC and produced by Unifax for property, general liability, CMP property, CMP liability and other miscellaneous coverages, subject to certain maximum policy limits. Policies placed with USIC by Unifax and reinsured with Crusader prior to November 24, 2020 remain in place without interruption or change and are subject to the New Reinsurance Agreement. On November 24, 2020, USIC and Unifax entered into a Surplus Line Broker Agreement, effective April 1, 2020 (the “Broker Agreement”), pursuant to which, and subject to the terms, conditions and limitations set forth therein, USIC authorized Unifax to act as its broker and agent for the purpose of producing and administering certain specified classes of insurance policies, which are the subject of the New Reinsurance Agreement. Under the Broker Agreement, Unifax is entitled to retain a commission for policies produced based on a percentage of the premiums on business placed with USIC. Unifax has agreed to indemnify and hold USIC harmless from any losses relating to the Broker Agreement. The Broker Agreement may be terminated in specified events, including by any party upon 90 days written notice to the other parties and automatically upon cancellation or termination of the New Reinsurance Agreement. On November 24, 2020, USIC and U.S. Risk Managers, Inc. (“U.S. Risk”), a subsidiary of the Company, entered into a Claims Administration Agreement, effective as of April 1, 2020 (the “Claims Administration Agreement”). Pursuant to the Claims Administration Agreement, USIC appointed U.S. Risk, which is a licensed claims adjuster in the state of California, to adjust and settle claims on its behalf in connection with the surplus lines policies issued by USIC in connection with the New Reinsurance Agreement. U.S. Risk will be paid a fee by Unifax on behalf of USIC based on a percentage of earned premium. U.S. Risk will establish an account for payment of claims by U.S. Risk (the “Loss Fund Account”) pursuant to the Claims Administration Agreement. Pursuant to the terms of the New Reinsurance Agreement, Crusader will fund the Loss Fund Account provided for in the Claims Administration Agreement on behalf of USIC.U.S. Risk has agreed to indemnify and hold USIC harmless from any losses relating to the Claims Administration Agreement. The Claims Administration Agreement may be terminated in specified events, including by any party upon 90 days written notice to the other parties and automatically upon cancellation or termination of the Broker Agreement. Crusader has no reinsurance recoverable balances in dispute. On most of the premium that Crusader cedes to the reinsurer, the reinsurer pays a commission to Crusader that includes a reimbursement of the cost of acquiring the portion of the premium that is ceded. Crusader intends to continue obtaining reinsurance although the availability and cost may vary from time to time. The unpaid losses and loss adjustment expenses ceded to the reinsurer are recorded as an asset on the Consolidated Balance Sheets. The effect of reinsurance on written premium, earned premium, and incurred losses and loss adjustment expenses is as follows: Year ended December 31 2020 2019 Written premium: Direct $ 36,338,800 $ 35,803,950 Assumed 304,030 — Ceded (8,078,748 ) (7,153,130 ) Net written premium $ 28,564,082 $ 28,650,820 Earned premium: Direct $ 36,108,230 $ 33,958,202 Assumed 156,639 — Ceded (8,096,701 ) (7,220,734 ) Net earned premium $ 28,168,168 $ 26,737,468 Incurred losses and loss adjustment expenses: Direct $ 48,971,172 $ 36,712,252 Assumed 89,204 — Ceded (14,417,456 ) (14,136,125 ) Net incurred losses and loss adjustment expenses $ 34,642,920 $ 22,576,127 Ceded earned premium as a percentage of gross earned premium (direct and assumed earned premium) was 22% in 2020 and 21% in 2019.

Retirement Plans

Retirement Plans	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Retirement Plans	NOTE 13 – PROFIT SHARING PLAN The Unico American Corporation Profit Sharing Plan (“Plan”) covers Company’s employees who are at least 21 years of age and have met certain service and eligibility requirements. Unico American Corporation is the Plan sponsor and the Plan administrator. Fidelity Management Trust Company is the Plan trustee. The Plan is intended to be a qualified retirement plan under the Internal Revenue Code. As required by the Plan, on an annual basis, the Company must contribute 3% of participants’ eligible compensation to the account of each participant. In addition, pursuant to the terms of the Plan, the Company may contribute to participants an amount determined by the Board. Under the Plan, participants have the option to make 401(k) and/or Roth 401(k) deferral contributions which are not matched by the Company. Participants must be employed by the Company on the last day of the Plan year and must have met certain service and eligibility requirements to be eligible for a contribution. Participants are eligible to request a distribution of their vested account balance upon death, retirement, minimum required distributions and termination of employment. Contributions to the Plan are as follows: Year ended December 31, 2020 $ 154,331 Year ended December 31, 2019 $ 138,670

Statutory Capital and Surplus

Statutory Capital and Surplus	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Statutory Capital and Surplus	NOTE 14 – STATUTORY CAPITAL AND SURPLUS Crusader is required to file statutory financial statements with insurance regulatory authorities prepared on an accounting basis prescribed or permitted by such authorities. Statutory accounting practices differ in certain respects from GAAP. The more significant of the differences for statutory accounting practices are (a) policy acquisition and commission costs are expensed when incurred rather than over the periods covered by the policies; (b) fixed maturity securities are reported at amortized cost, or the lower of amortized cost or fair value, depending on the quality of the security as specified by the National Association of Insurance Commissioners (“NAIC”); (c) non-admitted assets are charged directly against surplus; (d) loss and loss adjustment expense reserves and unearned premium reserves are stated net of reinsurance; (e) federal income taxes are recorded when payable and deferred taxes, subject to limitations, are recognized but only to the extent that they do not exceed a specified percentage of statutory surplus; and (f) changes in deferred taxes are recorded directly to surplus as regards policyholders. Additionally, the cash flow presentation is not consistent with GAAP and reconciliation from net income to cash provided by operations is not presented. Comprehensive income is not presented under statutory accounting practices. Crusader’s statutory capital and surplus are as follows: As of December 31, 2020 $ 26,893,515 As of December 31, 2019 $ 46,498,960 Crusader’s statutory net loss is as follows: Year ended December 31, 2020 $ (12,862,588 ) Year ended December 31, 2019 $ (2,190,703 ) The California Department of Insurance (“CA DOI”) conducts periodic financial examinations of Crusader. During 2017, the CA DOI completed a financial examination of Crusader’s December 31, 2015, statutory financial statements. On June 23, 2017, a report of examination was officially filed and became part of the records of the CA DOI. The Company has complied with all comments and recommendations identified in the report of examination, and none of the issues in that report of examination had any material effect on Crusader. The Company believes that Crusader’s statutory capital and surplus are sufficient to support the written premium guidelines established by the NAIC. Crusader is restricted in the amount of dividends it may pay to its parent in any 12-month period without prior approval of the CA DOI. Presently, without prior regulatory approval, Crusader may pay a dividend in any 12-month period to Unico up to the greater of (a) 10% of its statutory surplus or (b) its statutory net income for the preceding calendar year. Based on Crusader’s statutory surplus for the year ended December 31, 2020, the maximum dividend that could be made by Crusader to Unico without prior regulatory approval in 2021 is $2,689,351. During the years ended December 31, 2020 and 2019, Crusader issued cash dividends of $4,000,000 and $2,000,000 to Unico, respectively. The NAIC uses a Risk-Based Capital (“RBC”) Model Law for property and casualty companies. The RBC Model Law is intended to provide standards for calculating a variable regulatory capital requirement related to a company’s current operations and its risk exposures (asset risk, underwriting risk, credit risk and off-balance sheet risk). These standards are intended to serve as a diagnostic solvency tool for regulators that establishes uniform capital levels and specific authority levels for regulatory intervention when an insurer falls below minimum capital levels. The RBC Model Law specifies four distinct action levels at which a regulator can intervene with increasing degrees of authority over a domestic insurer if its RBC Crusader’s adjusted capital below 300% as of December 31, 2020, and combined loss ratio in excess of 120% for the year ended December 31, 2020, triggered a company action level event. Crusader has submitted to the insurance commissioner of the CA DOI a comprehensive plan to increase the adjusted capital above 300% to resolve the company action level event and is awaiting response from the CA DOI.

Incentive Stock Plans

Incentive Stock Plans	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Stock Plans	NOTE 15 – STOCK PLANS The Unico American Corporation 2011 Incentive Stock Plan (“2011 Plan”) covers 200,000 shares of the Company’s common stock (subject to adjustment in the case of stock splits, reverse stock splits, stock dividends, etc.) and was approved by shareholders on May 26, 2011. No options were granted to employees or non-employees during the years ended December 31, 2020 and 2019. As of December 31, 2020 and 2019, there was no unrecognized compensation cost. There were no stock options outstanding at December 31, 2020 and 2019. As of December 31, 2020, 100,000 share of the Company’s common stock were available under the 2011 Plan.

Taxes on Income

Taxes on Income	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Taxes on Income	NOTE 16 – TAXES ON INCOME The provision for taxes on income consists of the following: Year ended December 31 2020 2019 Federal expense (benefit): Current $ — $ 13,809 Deferred 3,566,840 (51,809 ) Total tax expense (benefit) $ 3,566,840 $ (38,000 ) State expense (benefit): Current $ 8,800 $ 8,800 Deferred (28,042 ) (104,987 ) Total tax benefit $ (19,242 ) $ (96,187 ) Total expense (benefit): Current $ 8,800 $ 22,609 Deferred 3,538,798 (156,796 ) Total tax expense (benefit) $ 3,547,598 $ (134,187 ) The income tax provision reflected in the Consolidated Statements of Operations is different than the expected federal income tax rate of 21% on income as shown in the following table: Year ended December 31 2020 2019 Computed income tax benefit at 21% $ (3,768,138 ) $ (682,477 ) Tax effect of: State tax benefit, net of federal tax benefit (572,511 ) (139,765 ) Change in valuation allowance – state net operating losses 557,310 63,777 Change in valuation allowance – federal 7,319,959 600,000 Other, including nondeductible expenses 10,920 23,989 Other – prior year true up 58 289 Income tax expense (benefit) $ 3,547,598 $ (134,187 ) Significant components of the Company’s net deferred tax assets and liabilities are as follows: Year ended December 31 2020 2019 Deferred tax assets: Discount on loss reserves $ 531,845 $ 329,065 Unearned premium 759,659 747,217 Unearned commission income 438,574 432,969 Unearned policy fee income 127,293 145,533 Net operating loss carryforwards 7,769,603 4,145,783 State net operating loss carryforwards 2,402,438 1,931,665 Bad debt reserve 333,649 336,075 Other 237,803 205,292 Total gross deferred tax assets 12,600,864 8,273,599 Less valuation allowance 10,557,080 2,531,665 Total deferred tax assets $ 2,043,784 $ 5,741,934 Deferred tax liabilities: Policy acquisition costs $ 858,705 $ 892,349 State tax on undistributed insurance company earnings 84,219 343,735 Federal tax liability on state deferred tax assets 91,277 90,461 Depreciation and amortization 266,880 175,524 Unrealized gains on investments 742,703 314,433 Total deferred tax liabilities $ 2,043,784 $ 1,816,502 Net deferred tax assets $ — $ 3,925,432 The Company recognizes deferred tax assets and liabilities for the future tax consequences related to differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases, and for tax credits. The Company evaluates its deferred tax assets for recoverability based on available evidence, including assumptions about future profitability, reversal patterns of recorded deferred tax assets and deferred tax liabilities, and capital gain generation. Some or all of the Company’s deferred tax assets could expire unused if the Company is unable to generate taxable income of a sufficient nature in the future to utilize them. If the Company determines it is more-likely-than-not that it would not be able to realize all or a portion of its deferred tax assets in the future, the Company would reduce the deferred tax asset through a charge to earnings in the period in which the determination is made. This charge could have a materially adverse effect on the Company’s results of operations and financial condition. In addition, the assumptions used to make this determination are subject to change from period to period based on changes in tax laws or variances between the Company’s projected operating performance and actual results. As a result, management’s judgment is required in assessing the possible need for a deferred tax asset valuation allowance. As of December 31, 2020, the Company had deferred tax assets of $7,769,603 generated from $36,998,110 of federal net operating loss carryforwards that will begin to expire in 2035 and deferred tax assets of $2,402,438 generated from state net operating loss carryforwards which expire between 2028 and 2040. In connection with preparation of its consolidated financial statements, the Company periodically performs an analysis of future income projections to determine the adequacy of the valuation allowance. In light of the net losses that were generated in recent years, for the twelve months ended December 31, 2020, the Company has established a valuation allowance for the aggregate amount of the federal and state net operating losses and other deferred tax assets in the amount of $10,557,080 that, in management’s judgment, are not more-likely-than-not to be realized. For the year ended December 31, 2019, the Company carried a valuation allowance on deferred tax assets generated from federal and state net operating losses in the amount of $600,000 and $1,931,665, respectively. The current federal effected state tax rate is 6.98%. The Company and its subsidiaries file consolidated federal and state income tax returns. Pursuant to the tax allocation agreement, Crusader and AAC are allocated taxes, or tax credits in the case of losses, at current corporate rates based on their own taxable income or loss. The Company files income tax returns under U.S. federal and various state jurisdictions. The Company is subject to examination by U.S. federal income tax authorities for tax returns filed starting at taxable year 2017 and California state income tax authorities for tax returns filed starting at taxable year 2016. There are no ongoing examinations of income tax returns by federal or state tax authorities. As a California insurance company, Crusader is obligated to pay a premium tax on direct written premium in all states where Crusader is admitted. Premium taxes are deferred and amortized as the related premium is earned. The premium tax is in lieu of state franchise taxes and is not included in the provision for state taxes. As of December 31, 2020, the Company had no unrecognized tax benefits, no unrecognized additional liabilities or reduction in deferred tax asset, and no uncertain tax positions. In addition, the Company had not accrued interest and penalties related to unrecognized tax benefits. However, if interest and penalties would need to be accrued related to unrecognized tax benefits, such amounts would be recognized as a component of federal income tax expense.

Repurchase of Common Stock

Repurchase of Common Stock	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Repurchase of Common Stock	NOTE 17 – REPURCHASE OF COMMON STOCK – EFFECT ON STOCKHOLDERS’ EQUITY On August 10, 2020, the Board authorized a share repurchase program (the “2020 Program”) for up to $5,000,000 of the currently outstanding shares of the Company’s common stock. The 2020 Program is effective immediately and replaces the Company’s existing share repurchase program that was adopted by the Board on December 19, 2008 (the “2008 Program”) to acquire from time to time up to an aggregate of 500,000 shares of the Company’s common stock. The purchases under the 2020 Program may be made from time to time in the open market, through block trades, 10b5-1 trading plans, privately negotiated transactions or otherwise and in accordance with applicable laws, rules and regulations. The timing and actual number of the shares repurchased under the 2020 Program will depend on a variety of factors including price, market conditions and corporate and regulatory requirements. The Company intends to fund the share repurchases under the 2020 Program from cash on hand. The 2020 Program does not commit the Company to repurchase shares of its common stock and it may be amended, suspended or discontinued at any time. The Company repurchased its shares under the 2020 Program and 2008 Program in unsolicited transactions as follows: December 31 December 31 2020 2019 2020 Program Number of shares repurchased 857 — Cost of shares repurchased Allocated to retained earnings $ 4,071 $ Allocated to capital 422 — Total cost of shares repurchased $ 4,493 $ — 2008 Program Number of shares repurchased 978 383 Cost of shares repurchased Allocated to retained earnings $ 5,760 $ 2,108 Allocated to capital 480 188 Total cost of shares repurchased $ 6,240 $ 2,296 The Company has remaining authority under the 2020 Program to repurchase up to $4,995,507 of the currently outstanding shares of the Company’s common stock as of December 31, 2020. The Company has retired or will retire all stock repurchased under the 2020 Program and 2008 Program.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Related Party Transactions	NOTE 18 – RELATED PARTY TRANSACTIONS Wish Properties Inc., an office of Wish Sotheby’ International Reality, owned by Ernest A. Wish, a member of the Company’s Board of Directors, leased 4,189 square feet at the Calabasas building. The lease commenced on July 13, 2017 and had a six month term. Effective January 8, 2018, the lease was amended to extend its termination date until January 11, 2019, and to allow an option to extend the term of the lease for three additional twelve month terms commencing on January 11, 2019. The lease ended on February 11, 2019. The monthly lease payment was $8,378 through February 11, 2019. The Company believes the terms of the lease were at least as favorable to the Company as could have been obtained from other third parties. Altonji Consulting, LLC, owned by Gerard Altonji, a member of the Company’s Board of Directors, was engaged to provide consulting services for a $20,000 fee of which $15,000 was paid during the year ended December 31, 2020.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Earnings Per Share	NOTE 19 – LOSS PER SHARE A reconciliation of the numerator and denominator used in the basic and diluted loss per share calculation is presented as follows: Year ended December 31 2020 2019 Basic Loss Per Share Net loss numerator $ (21,491,113 ) $ (3,115,703 ) Weighted average shares outstanding denominator 5,305,829 5,306,879 Per share amount $ (4.05 ) $ (0.59 ) Diluted Loss Per Share Net loss numerator $ (21,491,113 ) $ (3,115,703 ) Weighted average shares outstanding 5,305,829 5,306,879 Effect of diluted securities — — Diluted shares outstanding denominator 5,305,829 5,306,879 Per share amount $ (4.05 ) $ (0.59 ) As of December 31, 2020 and 2019, the Company had no common share equivalents that were excluded in the diluted loss per share calculation for years ended December 31, 2020 and 2019.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 20 – SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued. Except as disclosed below and elsewhere, no events have occurred subsequent to December 31, 2020 requiring disclosure or recording in the consolidated financial statements. On February 12, 2021, the Company, through Crusader, completed the sale of the Company’s headquarters at 26050 Mureau Road, Calabasas, California 91302, for approximately $12,695,000 (the “Sale”) to Mureau Road, LLC (“Mureau Road”), a subsidiary of Alliant Capital, Ltd. (“Alliant”). Mureau Road and Alliant do not have any material relationship with the Company or its subsidiaries, other than through the Sale and the Lease (as defined below) transactions. The Company recognized a gain of $4,359,982 and incurred selling costs of $666,124 on the sale of the building. On February 12, 2021, the Standard-Multi Tenant Office Lease – Net, dated January 28, 2021 (the “Lease”), by and between Crusader and Mureau Road became effective in connection with the completion of the Sale. The Company has agreed to a one-year lease with Alliant for the second floor of the Property with an initial base rent of approximately $52,637 per month, where the Company will continue to operate its corporate headquarters.

Selected Quarterly Financial Da

Selected Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Selected Quarterly Financial Data (Unaudited)	NOTE 21 – SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED) Summarized unaudited quarterly financial data for each of the calendar years 2020 and 2019 is as follows: Comparable Period by Quarter Ended March 31 June 30 September 30 December 31 Calendar Year 2020 Total revenues $ 8,005,181 $ 7,976,227 $ 8,259,686 $ 8,319,017 Loss before taxes $ (1,145,498 ) $ (384,562 ) $ (14,345,916 ) $ (2,067,539 ) Net loss $ (1,043,826 ) $ (434,814 ) $ (17,940,488 ) $ (2,071,985 ) Loss per share: Basic $ (0.20 ) $ (0.08 ) $ (3.38 ) $ (0.39 ) Diluted $ (0.20 ) $ (0.08 ) $ (3.38 ) $ (0.39 ) Calendar Year 2019 Total revenues $ 7,135,474 $ 7,795,098 $ 8,258,966 $ 8,183,276 Income (loss) before taxes $ (811,732 ) $ (342,670 ) $ 330,726 $ (2,426,214 ) Net income (loss) $ (671,074 ) $ (276,677 ) $ 212,467 $ (2,380,419 ) Income (loss) per share: Basic $ (0.13 ) $ (0.05 ) $ 0.04 $ (0.45 ) Diluted $ (0.13 ) $ (0.05 ) $ 0.04 $ (0.45 )

Supplementary Information on Lo

Supplementary Information on Loss and ALAE Development (Unaudited)	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Supplementary Information on Loss and ALAE Development (Unaudited)	NOTE 22 – SUPPLEMENTARY INFORMATION ON LOSS AND ALAE DEVELOPMENT (UNAUDITED) The following table presents cumulative incurred losses and ALAE, net of reinsurance, for years ended December 31: Accident Year 2011 (1) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 2011 18,120,563 17,900,250 17,605,460 17,014,895 17,879,595 18,224,634 19,187,240 19,094,732 19,156,281 19,150,281 2012 18,511,598 19,532,022 18,895,666 18,344,175 18,050,131 17,914,837 18,235,335 18,355,031 18,327,346 2013 19,570,946 20,118,343 20,323,841 21,742,580 22,798,398 22,397,394 22,859,132 22,802,931 2014 16,884,731 15,394,995 14,930,960 17,640,211 18,034,749 17,898,306 18,048,285 2015 20,452,199 20,840,034 22,471,512 21,707,615 23,006,844 24,495,614 2016 21,646,663 22,908,016 24,126,775 25,677,378 26,337,621 2017 21,914,736 23,453,130 23,876,588 25,091,934 2018 19,048,233 18,099,500 20,670,880 2019 17,349,941 19,182,851 2020 24,302,958 (1) The information for the years 2011 through 2019 is presented as unaudited required supplementary information. The following table presents cumulative paid losses and ALAE, net of reinsurance, for years ended December 31: Accident Year 2011 (1) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 2011 4,719,943 8,608,287 11,212,490 14,251,525 16,115,802 17,422,583 19,027,232 19,087,866 19,133,302 19,150,278 2012 6,719,982 11,673,621 13,411,125 15,369,629 16,734,967 17,265,513 17,638,646 18,001,581 18,020,565 2013 7,594,731 10,656,777 14,319,057 19,067,334 21,415,490 21,875,978 22,364,215 22,802,275 2014 3,826,263 6,082,893 9,173,947 14,556,687 16,843,128 17,487,722 17,806,537 2015 6,263,796 11,151,955 14,978,639 17,700,688 20,148,880 21,502,400 2016 7,435,120 12,009,273 15,916,432 21,438,785 23,326,143 2017 6,405,641 11,503,228 15,289,400 18,869,369 2018 4,959,689 9,254,754 12,129,118 2019 4,292,275 7,603,418 2020 6,004,292 (1) The information for the years 2011 through 2019 is presented as unaudited required supplementary information. The following table presents average annual percentage payout of incurred claims by age, net of reinsurance, as of December 31, 2020: Years 1 2 3 4 5 6 7 8 9 10 26.6 % 18.8 % 14.9 % 15.8 % 8.3 % 3.3 % 1.9 % 0.7 % 0.4 % 0.4 %

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Business Unico American Corporation (the “Company” or “Unico”) is an insurance holding company that underwrites property and casualty insurance through its insurance company subsidiary; provides property, casualty, and health insurance through its agency subsidiaries; and provides insurance premium financing and membership association services through its other subsidiaries. References to Unico or the Company include both the corporation and its subsidiaries, all of which are wholly owned. Unico was incorporated under the laws of Nevada in 1969. Principles of Consolidation The accompanying consolidated financial statements include the accounts of Unico American Corporation and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Basis of Presentation The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”). As described in Note 14, the Company's insurance subsidiary also files financial statements with regulatory agencies prepared on a statutory basis of accounting that differs from GAAP. Certain reclassifications have been made to prior period amounts to conform to the current year’s presentation. Use of Estimates in the Preparation of the Financial Statements The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect its reported amounts of assets and liabilities and its disclosure of any contingent assets and liabilities at the date of its financial statements, as well as its reported amounts of revenues and expenses during the reporting period. The most significant assumptions in the preparation of these consolidated financial statements relate to losses and loss adjustment expenses. While every effort is made to ensure the integrity of such estimates, actual results may differ. Investments The Company’s fixed maturity investments are classified either as held-to-maturity or available-for-sale and are stated at fair value. Although part of the Company's investments is classified as available-for-sale and the Company may sell investment securities from time to time in response to economic and market conditions, , its investment guidelines fair value. The unrealized gains or losses net of any deferred tax effect. When a decline in the value of a fixed maturity is The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income security whose carrying value may be other-than-temporarily impaired. For each fixed income security in an unrealized loss position, the Company assesses whether it is more likely than not that the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes, or the credit quality of the underlying security. If a security meets this criteria, the security's decline in fair value is considered other than temporary and is recorded as a net realized investment loss in the Consolidated Statements of Operations and in the Consolidated Statements of Comprehensive Income (Loss) based on the specific identification method. There were no realized investments gains (losses) from other than temporary impairments for any of the periods presented in the accompanying Consolidated Statements of Operations. For each fixed income security that the Company does not intend to sell or for which it is more likely than not that the Company would not be required to sell before an anticipated recovery in value, the Company separates the credit loss component of the impairment, if any, from the amount related to all other factors and reports the credit loss component in net realized investment gains (losses). There was no credit loss component for any of the periods presented in the accompanying Consolidated Statements of Operations. The short-term investments include U.S. Treasury bills, certificates of deposit, and commercial paper that are all highly rated and have initial maturity between three and twelve months. Fair Value of Financial Instruments The Company employs a fair value hierarchy that prioritizes the inputs for valuation techniques used to measure fair value. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price). Financial assets and financial liabilities recorded on the Consolidated Balance Sheets at fair value are categorized based on the reliability of inputs to the valuation techniques. (See Note 5.) The Company has used the following methods and assumptions in estimating its fair value disclosures for instruments carried at fair value: Available-for-sale fixed securities, equity securities, and short-term investments – Fair values are obtained from widely accepted third party vendors. The Company has used the following methods and assumptions for estimating fair value for other financial instruments not carried at fair value: Cash and cash equivalents – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. Long-term certificates of deposit – The carrying amounts reported in the Consolidated Balance Sheets for these instruments are at amortized cost which approximates their fair value Receivables, net – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. Accrued expenses and other liabilities – The carrying amounts reported in the Consolidated Balance Sheets approximate the fair values given the short-term nature of these instruments. Property and Equipment All property and equipment held for use is stated at cost less accumulated depreciation and amortization on the Consolidated Balance Sheets. Depreciation on building, is computed using the straight-line method over 39 years. Improvements to the building structure are amortized over the useful life of the improvements. Depreciation on computed using the straight-line method over 3 to 15 years. Amortization of tenant improvements in the Calabasas building was being computed using the shorter of the useful life of the tenant improvements or the remaining years of the lease. Income Taxes The Company and its subsidiaries file consolidated federal and state income tax returns. Pursuant to the tax allocation agreement, Crusader and American Acceptance Corporation (“AAC”), a subsidiary of Unico, are allocated taxes or tax credits in the case of losses, at current corporate rates based on their own taxable income or loss. The Company files income tax returns under U.S. federal and various state jurisdictions. The Company is subject to examination by U.S. federal income tax authorities for tax returns filed starting at taxable year 2017 and California state income tax authorities for tax returns filed starting at taxable year 2016. There are no ongoing examinations of income tax returns by federal or state tax authorities. As a California insurance company, Crusader is obligated to pay a premium tax on direct written premium in all states that Crusader is admitted. Premium taxes are deferred and amortized as the related premium is earned. The premium tax is in lieu of state franchise taxes and is not included in the provision for state taxes. The provision for federal income taxes is computed on the basis of income as reported for financial reporting purposes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and are measured using the enacted tax rates and laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Income tax expense provisions increase or decrease in the same period in which a change in tax rates is enacted. At each balance sheet date, management assesses the need to establish a valuation allowance that reduces deferred tax assets when it is more-likely-than-not that any portion of the deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon generating sufficient taxable income of the appropriate character within the carryback and carryforward periods available under the tax law. Management considers the reversal of deferred tax liabilities, projected future taxable income of an appropriate nature and tax-planning strategies when making this assessment. In connection with preparation of its consolidated financial statements, the Company periodically performs an analysis of future income projections to determine the adequacy of the valuation allowance. In light of the net losses that were generated in recent years, for the twelve months ended December 31, 2020, the Company has established a valuation allowance for the aggregate amount of the federal and state net operating losses and other deferred tax assets in the amount of $10,557,080 that, in management’s judgment, are not more-likely-than-not to be realized. For the year ended December 31, 2019, the Company carried a valuation allowance on deferred tax assets generated from federal and state net operating losses in the amount of $600,000 and $1,931,665, respectively. Earnings Per Share Basic earnings per share exclude the impact of common share equivalents and are based upon the weighted average common shares outstanding. Diluted earnings per share utilize the average market price per share when applying the treasury stock method in determining common share dilution. When outstanding stock options are dilutive, they are treated as common share equivalents for purposes of computing diluted earnings per share and represent the difference between basic and diluted weighted average shares outstanding. In loss periods, the options are excluded from the calculation of diluted earnings per share, as the inclusion of such options would have an anti-dilutive effect. Revenue Recognition a. General Agency Operations Commissions from sales of health insurance are earned in income based on the satisfaction of a single performance obligation. Marketing, selling, billing, collecting, and administering health insurance policies are a series of distinct services combined as a one performance obligation, which is recognized in income monthly over the policy period. Premiums are collected upon the initial sale of health insurance policies and then monthly upon each subsequent periodic payment. As a result there are limited accounts receivable. Policy fee income is recognized on a pro-rata basis over the terms of the policies. b. Insurance Company Operation Premium is earned on a pro-rata basis over the terms of the policies. Premium applicable to the unexpired terms of policies in force are recorded as unearned premium. c. Insurance Premium Financing Operations Premium finance interest may be charged to policyholders who choose to finance insurance premium. Interest may be charged at rates that vary with the amount of premium financed. Premium finance interest, if any, is recognized using a method that approximates the interest (actuarial) method. Other charges and fees earned include late fees, returned check fees and payment processing fees that are earned when recorded. Losses and Loss Adjustment Expenses The liability for unpaid losses and loss adjustment expenses is based upon the accumulation of individual case estimates for losses reported prior to the close of the accounting period plus estimates based on experience and industry data for development of case estimates and for incurred but unreported losses and loss adjustment expenses. There is a high level of uncertainty inherent in the evaluation of the required loss and loss adjustment expense reserves for Crusader. The long-tailed nature of liability claims and the volatility of jury awards exacerbate that uncertainty. Crusader records The ultimate cost of claims is dependent upon future events, the outcomes of which are affected by many factors. Crusader’s claim reserving procedures and settlement philosophy, current and perceived social and economic inflation, current and future court rulings and jury attitudes, improvements in medical technology, and many other economic, scientific, legal, political, and social factors all can have significant effects on the ultimate costs of claims. Changes in Company operations and management philosophy also may cause actual developments to vary from the past. Since the emergence and disposition of claims are subject to uncertainties, the net amounts that will ultimately be paid to settle claims may vary significantly from the estimated amounts provided for in the accompanying consolidated financial statements. Any adjustments to reserves are reflected in the operating results of the periods in which they are made. Management believes that the aggregate reserves for losses and loss adjustment expenses are reasonable and adequate to cover the cost of claims, both reported and unreported. The Company applies judgment in determining estimates for reserves associated with anticipated recoveries of salvage and subrogation on paid losses and loss adjustment expenses. During the year ended December 31, 2019, the Company changed that estimate to be in-line with its historic salvage and subrogation recovery success pattern. The impact of that change was a $968,400 reduction in losses and loss adjustment expenses for the year ended December 31, 2019, and in unpaid losses and loss adjustment expenses. The change was accounted for as a change in accounting estimate. Restricted Funds Restricted funds are as follows: Year ended December 31 2020 2019 Premium trust funds (1) $ 1,595,135 $ 1,758,915 Assigned to state agencies (2) 710,000 710,000 Funds held as collateral (3) 787,653 — Total restricted funds $ 3,092,788 $ 2,468,915 (1) As required by law, the Company segregates from its operating accounts the premium collected from insureds that are payable to insurance companies into separate trust accounts. (2) $510,000 included in fixed maturity investments as of December 31, 2020 and 2019, and $200,000 included in short-term investments as of December 31, 2020 and 2019, are statutory deposits assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in states other than California. (3) Funds held as collateral by Comerica Bank & Trust, N. A. (“Comerica”) included in available-for-sale fixed maturities pursuant to the reinsurance trust agreement among Crusader, United Specialty Insurance Company (“USIC”) and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. Deferred Policy Acquisition Costs Policy acquisition costs consist of commissions, premium taxes, inspection fees, and certain other underwriting costs, which are related to the successful production of Crusader insurance policies. Policy acquisition costs that are eligible for deferral are deferred and amortized as the related premium is earned and are limited to their estimated realizable value Ceding commission applicable to the unexpired terms Reinsurance Crusader employs reinsurance to provide greater diversification of business allowing management to control exposure to potential losses arising from large risks by reinsuring certain levels of risk in various areas of exposure, to reduce the loss that may arise from catastrophes, and to provide additional capacity for growth. Prepaid reinsurance premium and reinsurance receivables are reported as assets and represent ceded unearned premium and reinsurance recoverable on both paid and unpaid losses and loss adjustment expenses, respectively. Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liability associated with the reinsured policies. Crusader evaluates each of its ceded reinsurance contracts at its inception to determine if there is sufficient risk transfer to allow the contract to be accounted for as reinsurance under current accounting literature. As of December 31, 2020, all such ceded contracts are accounted for as risk transfer reinsurance. Crusader evaluates and monitors the financial condition of its reinsurers and factors such as collection periods, disputes, applicable coverage defenses and other factors to assess the need for any allowance against anticipated reinsurance recoveries. No such allowance was considered necessary at December 31, 2020 or 2019. Concentration of Risks 99.9% of Crusader’s gross written premium was derived from California during the years ended December 31, 2020 and 2019. In 2020, approximately 30% and 56% of the $727,515 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. In 2019, approximately 39% and 49% of the $939,689 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. Crusader’s reinsurance recoverable on paid and unpaid losses and loss adjustment expenses is as follows: Year ended December 31 Name of Reinsurer A.M. Best Rating (1) 2020 2019 Renaissance Reinsurance U.S. Inc. A+ $ 11,906,416 $ 8,095,647 Hannover Ruck SE A+ 10,673,173 6,869,914 TOA Reinsurance Company of America A 295,188 438,308 Other A 172 7,827 Total $ 22,874,949 $ 15,411,696 (1) A.M. Best ratings are as of December 31, 2020. Stock-Based Compensation Share-based compensation expense for all share-based payment awards is based on the grant-date fair value estimated in accordance with the provisions of ASC Topic 718, “Compensation - Stock Compensation” using the modified prospective transition method. Recently Issued Accounting Standards Recently adopted standards In February 2016, the FASB issued ASU 2016-02 “Leases.” ASU 2016-02 requires lessees to recognize on the balance sheet the assets and liabilities for the rights and obligations created by all leases, including those historically accounted for as operating leases. The Company adopted ASU 2016-02 effective January 1, 2019. The adoption of ASU 2016-02 did not have a material impact to the Consolidated Statements of Operations and the Consolidated Balance Sheets. In August, 2018, the FASB issued ASU 2018-13 “Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 modifies the disclosure requirements for assets and liabilities measured at fair value. The amendments in this ASU require certain existing disclosure requirements to be modified or removed, and certain new disclosure requirements to be added. In addition, this ASU allows entities to exercise more discretion when considering fair value measurement disclosures. This ASU is effective for annual and interim reporting periods beginning after December 15, 2019. The Company adopted ASU 2018-13 effective January 1, 2020. The adoption of ASU 2018-13 did not have a material impact to the Company’s disclosures. Standards not yet adopted In June 2016, the FASB issued ASU 2016-13 “Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 replaces the current incurred loss methodology for recognizing credit losses with a current expected credit loss model, which requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 also requires enhanced disclosures for better understanding of significant estimates and judgments used in estimating credit losses. The Company is currently evaluating the effect ASU 2016-13 will have on the Company's consolidated financial statements, but expects the primary changes to be (i) the use of the expected credit loss model for its premium receivables and reinsurance recoverables and (ii) the presentation of credit losses within the available-for-sale fixed maturities portfolio through an allowance method rather than as a direct write-down. ASU 2016-13 will primarily impact the Company’s available-for-sale fixed maturities portfolio and reinsurance recoverables. In November 2019, the FASB issued ASU 2019-10 “Financial Instruments – Credit Losses, Derivatives and Hedging, and Leases.” ASU 2019-10 updated the effective date for implementing ASU 2016-13 for smaller reporting entities, and that effective date will be for fiscal years beginning after December 15, 2022. Since the Company’s fixed income portfolio is invested primarily in higher rated bonds and the reinsurance is purchased from financially strong reinsurers, the Company believes the adoption of ASU 2016-13 will not have a material impact to the Consolidated Statements of Operations and the Consolidated Balance Sheets. In December of 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes or ASU 2019-12. ASU 2019-12 is expected to reduce the cost and complexity related to the accounting for income taxes. The ASU removes specific exceptions to the general principles in Topic 740 and improves the financial statement preparer's application of income tax related guidance. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.
Nature of Business	Nature of Business Unico American Corporation (the “Company” or “Unico”) is an insurance holding company that underwrites property and casualty insurance through its insurance company subsidiary; provides property, casualty, and health insurance through its agency subsidiaries; and provides insurance premium financing and membership association services through its other subsidiaries. References to Unico or the Company include both the corporation and its subsidiaries, all of which are wholly owned. Unico was incorporated under the laws of Nevada in 1969.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of Unico American Corporation and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Basis of Presentation	Basis of Presentation The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”). As described in Note 14, the Company's insurance subsidiary also files financial statements with regulatory agencies prepared on a statutory basis of accounting that differs from GAAP. Certain reclassifications have been made to prior period amounts to conform to the current year’s presentation.
Use of Estimates in the Preparation of the Financial Statements	Use of Estimates in the Preparation of the Financial Statements The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect its reported amounts of assets and liabilities and its disclosure of any contingent assets and liabilities at the date of its financial statements, as well as its reported amounts of revenues and expenses during the reporting period. The most significant assumptions in the preparation of these consolidated financial statements relate to losses and loss adjustment expenses. While every effort is made to ensure the integrity of such estimates, actual results may differ.
Investments	Investments The Company’s fixed maturity investments are classified either as held-to-maturity or available-for-sale and are stated at fair value. Although part of the Company's investments is classified as available-for-sale and the Company may sell investment securities from time to time in response to economic and market conditions, , its investment guidelines fair value. The unrealized gains or losses net of any deferred tax effect. When a decline in the value of a fixed maturity is The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income security whose carrying value may be other-than-temporarily impaired. For each fixed income security in an unrealized loss position, the Company assesses whether it is more likely than not that the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes, or the credit quality of the underlying security. If a security meets this criteria, the security's decline in fair value is considered other than temporary and is recorded as a net realized investment loss in the Consolidated Statements of Operations and in the Consolidated Statements of Comprehensive Income (Loss) based on the specific identification method. There were no realized investments gains (losses) from other than temporary impairments for any of the periods presented in the accompanying Consolidated Statements of Operations. For each fixed income security that the Company does not intend to sell or for which it is more likely than not that the Company would not be required to sell before an anticipated recovery in value, the Company separates the credit loss component of the impairment, if any, from the amount related to all other factors and reports the credit loss component in net realized investment gains (losses). There was no credit loss component for any of the periods presented in the accompanying Consolidated Statements of Operations. The short-term investments include U.S. Treasury bills, certificates of deposit, and commercial paper that are all highly rated and have initial maturity between three and twelve months.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company employs a fair value hierarchy that prioritizes the inputs for valuation techniques used to measure fair value. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price). Financial assets and financial liabilities recorded on the Consolidated Balance Sheets at fair value are categorized based on the reliability of inputs to the valuation techniques. (See Note 5.) The Company has used the following methods and assumptions in estimating its fair value disclosures for instruments carried at fair value: Available-for-sale fixed securities, equity securities, and short-term investments – Fair values are obtained from widely accepted third party vendors. The Company has used the following methods and assumptions for estimating fair value for other financial instruments not carried at fair value: Cash and cash equivalents – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. Long-term certificates of deposit – The carrying amounts reported in the Consolidated Balance Sheets for these instruments are at amortized cost which approximates their fair value Receivables, net – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. Accrued expenses and other liabilities – The carrying amounts reported in the Consolidated Balance Sheets approximate the fair values given the short-term nature of these instruments.
Property and Equipment	Property and Equipment All property and equipment held for use is stated at cost less accumulated depreciation and amortization on the Consolidated Balance Sheets. Depreciation on building, is computed using the straight-line method over 39 years. Improvements to the building structure are amortized over the useful life of the improvements. Depreciation on computed using the straight-line method over 3 to 15 years. Amortization of tenant improvements in the Calabasas building was being computed using the shorter of the useful life of the tenant improvements or the remaining years of the lease.
Income Taxes	Income Taxes The Company and its subsidiaries file consolidated federal and state income tax returns. Pursuant to the tax allocation agreement, Crusader and American Acceptance Corporation (“AAC”), a subsidiary of Unico, are allocated taxes or tax credits in the case of losses, at current corporate rates based on their own taxable income or loss. The Company files income tax returns under U.S. federal and various state jurisdictions. The Company is subject to examination by U.S. federal income tax authorities for tax returns filed starting at taxable year 2017 and California state income tax authorities for tax returns filed starting at taxable year 2016. There are no ongoing examinations of income tax returns by federal or state tax authorities. As a California insurance company, Crusader is obligated to pay a premium tax on direct written premium in all states that Crusader is admitted. Premium taxes are deferred and amortized as the related premium is earned. The premium tax is in lieu of state franchise taxes and is not included in the provision for state taxes. The provision for federal income taxes is computed on the basis of income as reported for financial reporting purposes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and are measured using the enacted tax rates and laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Income tax expense provisions increase or decrease in the same period in which a change in tax rates is enacted. At each balance sheet date, management assesses the need to establish a valuation allowance that reduces deferred tax assets when it is more-likely-than-not that any portion of the deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon generating sufficient taxable income of the appropriate character within the carryback and carryforward periods available under the tax law. Management considers the reversal of deferred tax liabilities, projected future taxable income of an appropriate nature and tax-planning strategies when making this assessment. In connection with preparation of its consolidated financial statements, the Company periodically performs an analysis of future income projections to determine the adequacy of the valuation allowance. In light of the net losses that were generated in recent years, for the twelve months ended December 31, 2020, the Company has established a valuation allowance for the aggregate amount of the federal and state net operating losses and other deferred tax assets in the amount of $10,557,080 that, in management’s judgment, are not more-likely-than-not to be realized. For the year ended December 31, 2019, the Company carried a valuation allowance on deferred tax assets generated from federal and state net operating losses in the amount of $600,000 and $1,931,665, respectively.
Earnings Per Share	Earnings Per Share Basic earnings per share exclude the impact of common share equivalents and are based upon the weighted average common shares outstanding. Diluted earnings per share utilize the average market price per share when applying the treasury stock method in determining common share dilution. When outstanding stock options are dilutive, they are treated as common share equivalents for purposes of computing diluted earnings per share and represent the difference between basic and diluted weighted average shares outstanding. In loss periods, the options are excluded from the calculation of diluted earnings per share, as the inclusion of such options would have an anti-dilutive effect.
Revenue Recognition	Revenue Recognition a. General Agency Operations Commissions from sales of health insurance are earned in income based on the satisfaction of a single performance obligation. Marketing, selling, billing, collecting, and administering health insurance policies are a series of distinct services combined as a one performance obligation, which is recognized in income monthly over the policy period. Premiums are collected upon the initial sale of health insurance policies and then monthly upon each subsequent periodic payment. As a result there are limited accounts receivable. Policy fee income is recognized on a pro-rata basis over the terms of the policies. b. Insurance Company Operation Premium is earned on a pro-rata basis over the terms of the policies. Premium applicable to the unexpired terms of policies in force are recorded as unearned premium. c. Insurance Premium Financing Operations Premium finance interest may be charged to policyholders who choose to finance insurance premium. Interest may be charged at rates that vary with the amount of premium financed. Premium finance interest, if any, is recognized using a method that approximates the interest (actuarial) method. Other charges and fees earned include late fees, returned check fees and payment processing fees that are earned when recorded.
Loss and Loss Adjustment Expenses	Losses and Loss Adjustment Expenses The liability for unpaid losses and loss adjustment expenses is based upon the accumulation of individual case estimates for losses reported prior to the close of the accounting period plus estimates based on experience and industry data for development of case estimates and for incurred but unreported losses and loss adjustment expenses. There is a high level of uncertainty inherent in the evaluation of the required loss and loss adjustment expense reserves for Crusader. The long-tailed nature of liability claims and the volatility of jury awards exacerbate that uncertainty. Crusader records The ultimate cost of claims is dependent upon future events, the outcomes of which are affected by many factors. Crusader’s claim reserving procedures and settlement philosophy, current and perceived social and economic inflation, current and future court rulings and jury attitudes, improvements in medical technology, and many other economic, scientific, legal, political, and social factors all can have significant effects on the ultimate costs of claims. Changes in Company operations and management philosophy also may cause actual developments to vary from the past. Since the emergence and disposition of claims are subject to uncertainties, the net amounts that will ultimately be paid to settle claims may vary significantly from the estimated amounts provided for in the accompanying consolidated financial statements. Any adjustments to reserves are reflected in the operating results of the periods in which they are made. Management believes that the aggregate reserves for losses and loss adjustment expenses are reasonable and adequate to cover the cost of claims, both reported and unreported. The Company applies judgment in determining estimates for reserves associated with anticipated recoveries of salvage and subrogation on paid losses and loss adjustment expenses. During the year ended December 31, 2019, the Company changed that estimate to be in-line with its historic salvage and subrogation recovery success pattern. The impact of that change was a $968,400 reduction in losses and loss adjustment expenses for the year ended December 31, 2019, and in unpaid losses and loss adjustment expenses. The change was accounted for as a change in accounting estimate.
Restricted Funds	Restricted Funds Restricted funds are as follows: Year ended December 31 2020 2019 Premium trust funds (1) $ 1,595,135 $ 1,758,915 Assigned to state agencies (2) 710,000 710,000 Funds held as collateral (3) 787,653 — Total restricted funds $ 3,092,788 $ 2,468,915 (1) As required by law, the Company segregates from its operating accounts the premium collected from insureds that are payable to insurance companies into separate trust accounts. (2) $510,000 included in fixed maturity investments as of December 31, 2020 and 2019, and $200,000 included in short-term investments as of December 31, 2020 and 2019, are statutory deposits assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in states other than California. (3) Funds held as collateral by Comerica Bank & Trust, N. A. (“Comerica”) included in available-for-sale fixed maturities pursuant to the reinsurance trust agreement among Crusader, United Specialty Insurance Company (“USIC”) and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC.
Deferred Policy Acquisition Costs	Deferred Policy Acquisition Costs Policy acquisition costs consist of commissions, premium taxes, inspection fees, and certain other underwriting costs, which are related to the successful production of Crusader insurance policies. Policy acquisition costs that are eligible for deferral are deferred and amortized as the related premium is earned and are limited to their estimated realizable value Ceding commission applicable to the unexpired terms
Reinsurance	Reinsurance Crusader employs reinsurance to provide greater diversification of business allowing management to control exposure to potential losses arising from large risks by reinsuring certain levels of risk in various areas of exposure, to reduce the loss that may arise from catastrophes, and to provide additional capacity for growth. Prepaid reinsurance premium and reinsurance receivables are reported as assets and represent ceded unearned premium and reinsurance recoverable on both paid and unpaid losses and loss adjustment expenses, respectively. Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liability associated with the reinsured policies. Crusader evaluates each of its ceded reinsurance contracts at its inception to determine if there is sufficient risk transfer to allow the contract to be accounted for as reinsurance under current accounting literature. As of December 31, 2020, all such ceded contracts are accounted for as risk transfer reinsurance. Crusader evaluates and monitors the financial condition of its reinsurers and factors such as collection periods, disputes, applicable coverage defenses and other factors to assess the need for any allowance against anticipated reinsurance recoveries. No such allowance was considered necessary at December 31, 2020 or 2019.
Concentration of Risk	Concentration of Risks 99.9% of Crusader’s gross written premium was derived from California during the years ended December 31, 2020 and 2019. In 2020, approximately 30% and 56% of the $727,515 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. In 2019, approximately 39% and 49% of the $939,689 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. Crusader’s reinsurance recoverable on paid and unpaid losses and loss adjustment expenses is as follows: Year ended December 31 Name of Reinsurer A.M. Best Rating (1) 2020 2019 Renaissance Reinsurance U.S. Inc. A+ $ 11,906,416 $ 8,095,647 Hannover Ruck SE A+ 10,673,173 6,869,914 TOA Reinsurance Company of America A 295,188 438,308 Other A 172 7,827 Total $ 22,874,949 $ 15,411,696 (1) A.M. Best ratings are as of December 31, 2020.
Stock Based Compensation	Stock-Based Compensation Share-based compensation expense for all share-based payment awards is based on the grant-date fair value estimated in accordance with the provisions of ASC Topic 718, “Compensation - Stock Compensation” using the modified prospective transition method.
Recently Issued Accounting Standards	Recently Issued Accounting Standards Recently adopted standards In February 2016, the FASB issued ASU 2016-02 “Leases.” ASU 2016-02 requires lessees to recognize on the balance sheet the assets and liabilities for the rights and obligations created by all leases, including those historically accounted for as operating leases. The Company adopted ASU 2016-02 effective January 1, 2019. The adoption of ASU 2016-02 did not have a material impact to the Consolidated Statements of Operations and the Consolidated Balance Sheets. In August, 2018, the FASB issued ASU 2018-13 “Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 modifies the disclosure requirements for assets and liabilities measured at fair value. The amendments in this ASU require certain existing disclosure requirements to be modified or removed, and certain new disclosure requirements to be added. In addition, this ASU allows entities to exercise more discretion when considering fair value measurement disclosures. This ASU is effective for annual and interim reporting periods beginning after December 15, 2019. The Company adopted ASU 2018-13 effective January 1, 2020. The adoption of ASU 2018-13 did not have a material impact to the Company’s disclosures. Standards not yet adopted In June 2016, the FASB issued ASU 2016-13 “Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 replaces the current incurred loss methodology for recognizing credit losses with a current expected credit loss model, which requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. ASU 2016-13 also requires enhanced disclosures for better understanding of significant estimates and judgments used in estimating credit losses. The Company is currently evaluating the effect ASU 2016-13 will have on the Company's consolidated financial statements, but expects the primary changes to be (i) the use of the expected credit loss model for its premium receivables and reinsurance recoverables and (ii) the presentation of credit losses within the available-for-sale fixed maturities portfolio through an allowance method rather than as a direct write-down. ASU 2016-13 will primarily impact the Company’s available-for-sale fixed maturities portfolio and reinsurance recoverables. In November 2019, the FASB issued ASU 2019-10 “Financial Instruments – Credit Losses, Derivatives and Hedging, and Leases.” ASU 2019-10 updated the effective date for implementing ASU 2016-13 for smaller reporting entities, and that effective date will be for fiscal years beginning after December 15, 2022. Since the Company’s fixed income portfolio is invested primarily in higher rated bonds and the reinsurance is purchased from financially strong reinsurers, the Company believes the adoption of ASU 2016-13 will not have a material impact to the Consolidated Statements of Operations and the Consolidated Balance Sheets. In December of 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes or ASU 2019-12. ASU 2019-12 is expected to reduce the cost and complexity related to the accounting for income taxes. The ASU removes specific exceptions to the general principles in Topic 740 and improves the financial statement preparer's application of income tax related guidance. The ASU is effective for fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.

Resticted Funds (Tables)

Resticted Funds (Tables)	12 Months Ended
	Dec. 31, 2020
Resticted Funds
Schedule of Restricted Funds	Restricted funds are as follows: Year ended December 31 2020 2019 Premium trust funds (1) $ 1,595,135 $ 1,758,915 Assigned to state agencies (2) 710,000 710,000 Funds held as collateral (3) 787,653 — Total restricted funds $ 3,092,788 $ 2,468,915 (1) As required by law, the Company segregates from its operating accounts the premium collected from insureds that are payable to insurance companies into separate trust accounts. (2) $510,000 included in fixed maturity investments as of December 31, 2020 and 2019, and $200,000 included in short-term investments as of December 31, 2020 and 2019, are statutory deposits assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in states other than California. (3) Funds held as collateral by Comerica Bank & Trust, N. A. (“Comerica”) included in available-for-sale fixed maturities pursuant to the reinsurance trust agreement among Crusader, United Specialty Insurance Company (“USIC”) and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC.

Concentration Of Risk - Reinsur

Concentration Of Risk - Reinsurance Recoverable (Tables)	12 Months Ended
	Dec. 31, 2020
Concentration Of Risk - Reinsurance Recoverable
Reinsurance recoverable	Crusader’s reinsurance recoverable on paid and unpaid losses and loss adjustment expenses is as follows: Year ended December 31 Name of Reinsurer A.M. Best Rating (1) 2020 2019 Renaissance Reinsurance U.S. Inc. A+ $ 11,906,416 $ 8,095,647 Hannover Ruck SE A+ 10,673,173 6,869,914 TOA Reinsurance Company of America A 295,188 438,308 Other A 172 7,827 Total $ 22,874,949 $ 15,411,696 (1) A.M. Best ratings are as of December 31, 2020.

Cash and Cash Equivalents (Tabl

Cash and Cash Equivalents (Tables)	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Cash and Cash Equivalents	The following table provides a reconciliation of cash and cash equivalents reported within the Consolidated Balance Sheets to the amounts shown in the Consolidated Statements of Cash Flows: 2020 2019 Cash $ 3,383,048 $ 2,490,902 Cash equivalents 574,932 3,290,737 Cash and cash equivalents $ 3,957,980 $ 5,781,639

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2020
Investments Tables Abstract
Summary of investment income and net realized gains	A summary of investment income, net of investment expenses, net realized gains, and net unrealized investment gains on equity securities is as follows: Year ended December 31 2020 2019 Fixed maturities $ 2,068,592 $ 2,162,142 Equities 28,727 — Short-term investments and cash equivalents 24,603 65,642 Gross investment income 2,121,922 2,227,784 Less investment expenses (133,679 ) (129,842 ) Net investment income 1,988,243 2,097,942 Net realized gains (losses) 97,771 (12,661 ) Net unrealized gains on equity securities 198,266 — Net investment income, realized gains (losses) and unrealized gains $ 2,284,280 $ 2,085,281
Investments by contractual maturity	The amortized cost and estimated fair value of fixed maturity investments at December 31, 2020, by contractual maturity are as follows: Amortized Cost Estimated Fair Value Due in one year or less $ 11,064,202 $ 11,169,232 Due after one year through five years 30,090,910 31,260,694 Due after five years through ten years 18,476,051 19,806,444 Due after ten years and beyond 21,238,117 21,971,324 Total fixed maturities $ 80,869,280 $ 84,207,694
Investments by amortized cost and estimated fair value	The amortized cost and estimated fair values of investments in fixed maturities by category are as follows: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value December 31, 2020 Available-for-sale fixed maturities: U.S. Treasury securities $ 10,596,808 $ 235,373 $ — $ 10,832,181 Corporate securities 44,159,926 2,347,826 (55,847 ) 46,451,905 Agency mortgage-backed securities 25,314,546 833,336 (22,274 ) 26,125,608 Held-to-maturity fixed maturities: Certificates of deposit 798,000 — — 798,000 Total fixed maturities $ 80,869,280 $ 3,416,535 $ (78,121 ) $ 84,207,694 December 31, 2019 Available-for-sale fixed maturities: U.S. Treasury securities $ 15,105,795 $ 130,564 $ (1,027 ) $ 15,235,332 Corporate securities 41,953,378 1,076,012 (57 ) 43,029,333 Agency mortgage-backed securities 24,943,238 293,757 (1,950 ) 25,235,045 Held-to-maturity fixed maturities: Certificates of deposit 798,000 — — 798,000 Total fixed maturities $ 82,800,411 $ 1,500,333 $ (3,034 ) $ 84,297,710
Summary of unrealized appreciation (depreciation) on investments	A summary of the unrealized gains (losses) on investments carried at fair value and the applicable deferred federal income taxes is as follows: Year ended December 31 2020 2019 Gross unrealized gains of fixed maturities $ 3,416,535 $ 1,500,333 Gross unrealized losses of fixed maturities (78,121 ) (3,034 ) Net unrealized gains on investments 3,338,414 1,497,299 Deferred federal tax expense (701,067 ) (314,433 ) Net unrealized gains, net of deferred income taxes $ 2,637,347 $ 1,182,866
Components of investments in unrealized loss position for continuous period of time	A summary of estimated fair value and gross unrealized losses in a gross unrealized loss position by the length of time in which the securities have continually been in that position is shown below: Less than 12 Months 12 Months or Longer Estimated Gross Unrealized Number of Securities Estimated Gross Unrealized Number of Securities December 31, 2020 U.S. Treasury securities $ — $ — — $ — $ — — Corporate securities 2,101,986 (55,847 ) 2 — — — Agency mortgage-backed securities 3,223,329 (22,274 ) 12 — — — Total debt securities 5,325,315 (78,121 ) 14 — — — Equity securities 723,346 (37,357 ) 25 — — — Total $ 6,048,661 $ (115,478 ) 39 $ — $ — — Less than 12 Months 12 Months or Longer Estimated Fair Value Gross Unrealized Losses Number of Securities Estimated Fair Value Gross Unrealized Losses Number of Securities December 31, 2019 U.S. Treasury securities $ 1,996,562 $ (253 ) 1 $ 1,002,031 $ (775 ) 1 Corporate securities 999,818 (56 ) 1 — — — Agency mortgage-backed securities 750,058 (1,950 ) 2 — — — Total $ 3,746,438 $ (2,259 ) 4 $ 1,002,031 $ (775 ) 1
Fixed maturities sold and called	Although the Company does not intend to sell its fixed maturity investments prior to maturity, the Company may sell investment securities from time to time in response to cash flow requirements, economic and/or market conditions or investment securities may be called by their issuers prior to the securities’ maturity. December 31 December 31 2020 2019 Fixed maturities securities sold Number of securities sold 15 3 Amortized cost of sold securities $ 5,529,470 $ 2,997,098 Realized gains (losses) on sales $ 52,053 $ (12,679 ) Fixed maturities securities called Number of securities called 4 1 Amortized cost of called securities $ 2,449,503 $ 999,982 Realized gains on calls $ 497 $ 18
Summary of equity investments	The Company started investing in common stock equity securities during the year ended December 31, 2020. The Company’s equity securities allocation is intended to enhance the return of and provide diversification for the total investment portfolio. A summary of equity securities is shown below: December 31 December 31 2020 2019 Cost $ 2,548,440 $ — Unrealized gain 198,266 — Fair market value of equity securities $ 2,746,706 $ —
Summary of state held deposits	The following securities from three different banks represent statutory deposits that are assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in the state of Nevada. Year ended December 31 2020 2019 Certificates of deposit $ 200,000 $ 200,000 Short-term investments 200,000 200,000 Total state held deposits $ 400,000 $ 400,000
Summary of short term investments	Short-term investments have an initial maturity of one year or less and consist of the following: Year ended December 31 2020 2019 U.S. Treasury bills $ — $ 1,996,815 Certificates of deposit 200,000 200,000 Total short-term investments $ 200,000 $ 2,196,815

Fair Value Of Financial Instr_2

Fair Value Of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2020
Fair Value Of Financial Instruments
Fair value of financial instruments	The following table presents information about the Company’s financial instruments and their estimated fair values, which are measured on a recurring basis, allocated among the three levels within the fair value hierarchy as of December 31, 2020 and 2019: Level 1 Level 2 Level 3 Total December 31, 2020 Financial instruments: Available-for-sale fixed maturities: U.S. Treasury securities $ 10,832,181 $ — $ — $ 10,832,181 Corporate securities — 46,451,905 — 46,451,905 Agency mortgage-backed securities — 26,125,608 — 26,125,608 Equity securities 2,746,706 — — 2,746,706 Short-term investments 200,000 — — 200,000 Total financial instruments at fair value $ 13,778,887 $ 72,577,513 $ — $ 86,356,400 December 31, 2019 Financial instruments: Available-for-sale fixed maturities: U.S. Treasury securities $ 15,235,332 $ — $ — $ 15,235,332 Corporate securities — 43,029,333 — 43,029,333 Agency mortgage-backed securities — 25,235,045 — 25,235,045 Short-term investments 2,196,815 — — 2,196,815 Total financial instruments at fair value $ 17,432,147 $ 68,264,378 $ — $ 85,696,525

Property And Equipment Summary

Property And Equipment Summary (Tables)	12 Months Ended
	Dec. 31, 2020
Property And Equipment Summary
Property and equipment summary	Property and equipment consist of the following: Year ended December 31 2020 2019 Real estate held for sale, located in Calabasas, California $ 10,202,676 $ — Accumulated depreciation and amortization (1,867,659 ) — Real estate held for sale, net $ 8,335,017 $ — Building and tenant improvements, located in Calabasas, California — 8,411,541 Furniture, fixtures, equipment 2,191,411 2,110,653 Computer software 467,275 459,899 Accumulated depreciation and amortization (2,423,617 ) (3,617,381 ) Computer software under development 1,803,346 1,074,398 Land located in Calabasas, California — 1,787,485 Property and equipment, net $ 2,038,415 $ 10,226,595

Summary of Receivables (Tables)

Summary of Receivables (Tables)	12 Months Ended
	Dec. 31, 2020
Summary Of Receivables
Summary of Receivables	Receivables, net, include premium, commissions and notes receivable and are as follows: Year ended December 31 2020 2019 Premium and commission receivable $ 2,476,679 $ 2,178,476 Premium finance notes receivable 2,036,960 3,041,931 Total premium and notes receivable 4,513,639 5,220,407 Allowance for doubtful accounts (1,192,302 ) (1,200,970 ) Receivables, net $ 3,321,337 $ 4,019,437

Unpaid Losses and Loss Adjust_2

Unpaid Losses and Loss Adjustment Expenses (Tables)	12 Months Ended
	Dec. 31, 2020
Unpaid Losses And Loss Adjustment Expenses
Unpaid losses and loss adjustment expenses	Crusader’s loss and loss adjustment expense case and incurred but not reported (“IBNR”) reserves are as follows: Year ended December 31 2020 2019 Gross reserves: Case reserves $ 26,363,695 $ 23,663,743 IBNR reserves 48,529,814 31,402,737 Total gross reserves $ 74,893,509 $ 55,066,480 Reserves net of reinsurance: Case reserves $ 21,027,703 $ 18,128,008 IBNR reserves 31,612,164 22,212,617 Total net reserves $ 52,639,867 $ 40,340,625
Reserves for loss and loss adjustment expenses by line of business	Reserves for losses and loss adjustment expenses before reinsurance for each of Crusader’s lines of business are as follows: Year ended December 31 Line of Business 2020 2019 CMP $ 73,545,181 98.2 % $ 54,270,633 98.6 % Other liability 1,283,174 1.7 % 776,957 1.4 % Other 65,154 0.1 % 18,890 0.0 % Total $ 74,893,509 100.0 % $ 55,066,480 100.0 %
Rollforward of loss and loss adjustment expense reserves	The following table provides an analysis of the roll forward of Crusader’s loss and loss adjustment expense reserves, including a reconciliation of the ending balance sheet liability for the periods indicated: Year ended December 31 2020 2019 Reserve for unpaid losses and loss adjustment expenses $ 40,340,625 $ 42,125,553 Incurred losses and loss adjustment expenses: Provision for insured events of current year 26,683,872 19,384,942 Provision for incurred events of prior years 7,959,048 3,191,185 Total incurred losses and loss adjustment expenses 34,642,920 22,576,127 Payments: Losses and loss adjustment expenses attributable to 8,285,021 6,210,475 Losses and loss adjustment expenses attributable to 14,058,657 18,150,580 Total payments 22,343,678 24,361,055 Reserve for unpaid losses and loss adjustment expenses at 52,639,867 40,340,625 Reinsurance recoverable on unpaid losses and loss 22,253,642 14,725,855 Reserve for unpaid losses and loss adjustment expenses at $ 74,893,509 $ 55,066,480
Incurred and paid claim development	The following table presents loss development information by accident year, including cumulative incurred and paid losses and allocated loss adjustment expenses (“ALAE”), net of reinsurance, as well as cumulative claim frequency and the total of incurred but not reported liabilities plus expected development on reported claims as of December 31, 2020: Accident Year Cumulative Incurred Cumulative Paid Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims Cumulative Number of Reported Claims 2011 $ 19,150,281 $ 19,150,278 $ — 1,020 2012 18,327,346 18,020,565 222 967 2013 22,802,931 22,802,275 2 849 2014 18,048,285 17,806,537 150,672 760 2015 24,495,614 21,502,400 635,716 749 2016 26,337,621 23,326,143 1,565,938 803 2017 25,091,934 18,869,369 3,060,474 807 2018 20,670,880 12,129,118 6,146,217 605 2019 19,182,851 7,603,418 7,134,966 639 2020 24,302,958 6,004,292 12,910,459 699 Total $ 218,410,701 $ 167,214,395 $ 31,604,666
Reconciliation of cumulative incurred and paid claims to unpaid losses and loss adjustment expenses	The following table reconciles the above cumulative incurred and paid data to Crusader’s loss and loss adjustment expense reserves: Year ended December 31 2020 2019 Cumulative incurred losses and ALAE $ 218,410,701 $ 203,000,161 Less cumulative paid losses and ALAE (167,214,395 ) (164,132,073 ) Reserve for unpaid losses and ALAE (latest 10 accident years) 51,196,306 38,868,088 Reserves for unpaid losses and ALAE (beyond latest 10 accident 79,703 126,042 Reserves for unpaid unallocated loss adjustment expenses 1,363,858 1,346,495 Reserve for unpaid losses and loss adjustment expenses, 52,639,867 40,340,625 Reinsurance recoverable on unpaid losses and loss adjustment 22,253,642 14,725,855 Reserve for unpaid losses and loss adjustment expenses, $ 74,893,509 $ 55,066,480

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs Roll Forward (Tables)	12 Months Ended
	Dec. 31, 2020
Deferred Policy Acquisition Costs Roll Forward
Deferred policy acquisition costs rollforward	The following table provides an analysis of the roll forward of the Company’s deferred policy acquisition costs: Year ended December 31 2020 2019 Deferred policy acquisition costs at beginning of year $ 3,619,594 $ 3,489,728 Policy acquisition costs deferred during year 4,782,461 5,090,712 Policy acquisition costs amortized during year (4,898,807 ) (4,960,846 ) Deferred policy acquisition costs at end of year $ 3,503,248 $ 3,619,594

Summary of Accrued Expenses and

Summary of Accrued Expenses and Other Liablilities (Tables)	12 Months Ended
	Dec. 31, 2020
Summary Of Accrued Expenses And Other Liablilities
Summary of accrued expenses and other liabilities	Accrued expenses and other liabilities consist of the following: Year ended December 31 2020 2019 Premium payable $ 393,466 $ 480,078 Unearned policy fee income 454,883 520,064 Retirement plans 145,473 112,827 Accrued salaries and employee benefits 973,504 501,414 Commission payable 869 1,764 Security deposit for Calabasas building sale 380,850 — Other 1,228,405 514,153 Total accrued expenses and other liabilities $ 3,577,450 $ 2,130,300

Reinsurance Agreements (Tables)

Reinsurance Agreements (Tables)	12 Months Ended
	Dec. 31, 2020
Reinsurance Agreements
Primary reinsurance agreements	Crusader’s primary excess of loss reinsurance agreements during the years ended December 31, 2020 and 2019 are as follows: Loss Year Reinsurers A.M. Best Rating Retention 2020 Renaissance Reinsurance U.S. Inc. A+ $ 500,000 2019 Renaissance Reinsurance U.S. Inc. A+ $ 500,000
Effect of reinsurance on premiums written, premiums earned, and incurred losses	The effect of reinsurance on written premium, earned premium, and incurred losses and loss adjustment expenses is as follows: Year ended December 31 2020 2019 Written premium: Direct $ 36,338,800 $ 35,803,950 Assumed 304,030 — Ceded (8,078,748 ) (7,153,130 ) Net written premium $ 28,564,082 $ 28,650,820 Earned premium: Direct $ 36,108,230 $ 33,958,202 Assumed 156,639 — Ceded (8,096,701 ) (7,220,734 ) Net earned premium $ 28,168,168 $ 26,737,468 Incurred losses and loss adjustment expenses: Direct $ 48,971,172 $ 36,712,252 Assumed 89,204 — Ceded (14,417,456 ) (14,136,125 ) Net incurred losses and loss adjustment expenses $ 34,642,920 $ 22,576,127

Profit Sharing Plan Expenses (T

Profit Sharing Plan Expenses (Tables)	12 Months Ended
	Dec. 31, 2020
Profit Sharing Plan Expenses
Profit sharing plan expenses	Contributions to the Plan are as follows: Year ended December 31, 2020 $ 154,331 Year ended December 31, 2019 $ 138,670

Statutory Net Income And Statut

Statutory Net Income And Statutory Capital And Surplus (Tables)	12 Months Ended
	Dec. 31, 2020
Statutory Net Income And Statutory Capital And Surplus
Statutory Capital and Surplus	Crusader’s statutory capital and surplus are as follows: As of December 31, 2020 $ 26,893,515 As of December 31, 2019 $ 46,498,960
Statutory Net Loss	Crusader’s statutory net loss is as follows: Year ended December 31, 2020 $ (12,862,588 ) Year ended December 31, 2019 $ (2,190,703 )

Taxes On Income (Tables)

Taxes On Income (Tables)	12 Months Ended
	Dec. 31, 2020
Taxes On Income
Provision for taxes	The provision for taxes on income consists of the following: Year ended December 31 2020 2019 Federal expense (benefit): Current $ — $ 13,809 Deferred 3,566,840 (51,809 ) Total tax expense (benefit) $ 3,566,840 $ (38,000 ) State expense (benefit): Current $ 8,800 $ 8,800 Deferred (28,042 ) (104,987 ) Total tax benefit $ (19,242 ) $ (96,187 ) Total expense (benefit): Current $ 8,800 $ 22,609 Deferred 3,538,798 (156,796 ) Total tax expense (benefit) $ 3,547,598 $ (134,187 )
Reconcilation of income tax provision and expected income tax	The income tax provision reflected in the Consolidated Statements of Operations is different than the expected federal income tax rate of 21% on income as shown in the following table: Year ended December 31 2020 2019 Computed income tax benefit at 21% $ (3,768,138 ) $ (682,477 ) Tax effect of: State tax benefit, net of federal tax benefit (572,511 ) (139,765 ) Change in valuation allowance – state net operating losses 557,310 63,777 Change in valuation allowance – federal 7,319,959 600,000 Other, including nondeductible expenses 10,920 23,989 Other – prior year true up 58 289 Income tax expense (benefit) $ 3,547,598 $ (134,187 )
Components of net deferred tax assets	Significant components of the Company’s net deferred tax assets and liabilities are as follows: Year ended December 31 2020 2019 Deferred tax assets: Discount on loss reserves $ 531,845 $ 329,065 Unearned premium 759,659 747,217 Unearned commission income 438,574 432,969 Unearned policy fee income 127,293 145,533 Net operating loss carryforwards 7,769,603 4,145,783 State net operating loss carryforwards 2,402,438 1,931,665 Bad debt reserve 333,649 336,075 Other 237,803 205,292 Total gross deferred tax assets 12,600,864 8,273,599 Less valuation allowance 10,557,080 2,531,665 Total deferred tax assets $ 2,043,784 $ 5,741,934 Deferred tax liabilities: Policy acquisition costs $ 858,705 $ 892,349 State tax on undistributed insurance company earnings 84,219 343,735 Federal tax liability on state deferred tax assets 91,277 90,461 Depreciation and amortization 266,880 175,524 Unrealized gains on investments 742,703 314,433 Total deferred tax liabilities $ 2,043,784 $ 1,816,502 Net deferred tax assets $ — $ 3,925,432

Repurchase of Common Stock (Tab

Repurchase of Common Stock (Tables)	12 Months Ended
	Dec. 31, 2020
Repurchase Of Common Stock
Common Stock Repurchase	On August 10, 2020, the Board authorized a share repurchase program (the “2020 Program”) for up to $5,000,000 of the currently outstanding shares of the Company’s common stock. The 2020 Program is effective immediately and replaces the Company’s existing share repurchase program that was adopted by the Board on December 19, 2008 (the “2008 Program”) to acquire from time to time up to an aggregate of 500,000 shares of the Company’s common stock. The purchases under the 2020 Program may be made from time to time in the open market, through block trades, 10b5-1 trading plans, privately negotiated transactions or otherwise and in accordance with applicable laws, rules and regulations. The timing and actual number of the shares repurchased under the 2020 Program will depend on a variety of factors including price, market conditions and corporate and regulatory requirements. The Company intends to fund the share repurchases under the 2020 Program from cash on hand. The 2020 Program does not commit the Company to repurchase shares of its common stock and it may be amended, suspended or discontinued at any time. The Company repurchased its shares under the 2020 Program and 2008 Program in unsolicited transactions as follows: December 31 December 31 2020 2019 2020 Program Number of shares repurchased 857 — Cost of shares repurchased Allocated to retained earnings $ 4,071 $ Allocated to capital 422 — Total cost of shares repurchased $ 4,493 $ — 2008 Program Number of shares repurchased 978 383 Cost of shares repurchased Allocated to retained earnings $ 5,760 $ 2,108 Allocated to capital 480 188 Total cost of shares repurchased $ 6,240 $ 2,296

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2020
Earnings Per Share Tables Abstract
Basic and diluted earnings per share calculation data	A reconciliation of the numerator and denominator used in the basic and diluted loss per share calculation is presented as follows: Year ended December 31 2020 2019 Basic Loss Per Share Net loss numerator $ (21,491,113 ) $ (3,115,703 ) Weighted average shares outstanding denominator 5,305,829 5,306,879 Per share amount $ (4.05 ) $ (0.59 ) Diluted Loss Per Share Net loss numerator $ (21,491,113 ) $ (3,115,703 ) Weighted average shares outstanding 5,305,829 5,306,879 Effect of diluted securities — — Diluted shares outstanding denominator 5,305,829 5,306,879 Per share amount $ (4.05 ) $ (0.59 )

Selected Quarterly Financial _2

Selected Quarterly Financial Data (Tables)	12 Months Ended
	Dec. 31, 2020
Selected Quarterly Financial Data
Selected quarterly unaudited financial data	Summarized unaudited quarterly financial data for each of the calendar years 2020 and 2019 is as follows: Comparable Period by Quarter Ended March 31 June 30 September 30 December 31 Calendar Year 2020 Total revenues $ 8,005,181 $ 7,976,227 $ 8,259,686 $ 8,319,017 Loss before taxes $ (1,145,498 ) $ (384,562 ) $ (14,345,916 ) $ (2,067,539 ) Net loss $ (1,043,826 ) $ (434,814 ) $ (17,940,488 ) $ (2,071,985 ) Loss per share: Basic $ (0.20 ) $ (0.08 ) $ (3.38 ) $ (0.39 ) Diluted $ (0.20 ) $ (0.08 ) $ (3.38 ) $ (0.39 ) Calendar Year 2019 Total revenues $ 7,135,474 $ 7,795,098 $ 8,258,966 $ 8,183,276 Income (loss) before taxes $ (811,732 ) $ (342,670 ) $ 330,726 $ (2,426,214 ) Net income (loss) $ (671,074 ) $ (276,677 ) $ 212,467 $ (2,380,419 ) Income (loss) per share: Basic $ (0.13 ) $ (0.05 ) $ 0.04 $ (0.45 ) Diluted $ (0.13 ) $ (0.05 ) $ 0.04 $ (0.45 )

Supplementary Information on _2

Supplementary Information on Loss and ALAE Development (Tables)	12 Months Ended
	Dec. 31, 2020
Notes to Financial Statements
Cumulative Incurred Loss and ALAE Development (Tables)	The following table presents cumulative incurred losses and ALAE, net of reinsurance, for years ended December 31: Accident Year 2011 (1) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 2011 18,120,563 17,900,250 17,605,460 17,014,895 17,879,595 18,224,634 19,187,240 19,094,732 19,156,281 19,150,281 2012 18,511,598 19,532,022 18,895,666 18,344,175 18,050,131 17,914,837 18,235,335 18,355,031 18,327,346 2013 19,570,946 20,118,343 20,323,841 21,742,580 22,798,398 22,397,394 22,859,132 22,802,931 2014 16,884,731 15,394,995 14,930,960 17,640,211 18,034,749 17,898,306 18,048,285 2015 20,452,199 20,840,034 22,471,512 21,707,615 23,006,844 24,495,614 2016 21,646,663 22,908,016 24,126,775 25,677,378 26,337,621 2017 21,914,736 23,453,130 23,876,588 25,091,934 2018 19,048,233 18,099,500 20,670,880 2019 17,349,941 19,182,851 2020 24,302,958 (1) The information for the years 2011 through 2019 is presented as unaudited required supplementary information.
Cumulative Paid Loss and ALAE Development (Tables)	The following table presents cumulative paid losses and ALAE, net of reinsurance, for years ended December 31: Accident Year 2011 (1) 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 2011 4,719,943 8,608,287 11,212,490 14,251,525 16,115,802 17,422,583 19,027,232 19,087,866 19,133,302 19,150,278 2012 6,719,982 11,673,621 13,411,125 15,369,629 16,734,967 17,265,513 17,638,646 18,001,581 18,020,565 2013 7,594,731 10,656,777 14,319,057 19,067,334 21,415,490 21,875,978 22,364,215 22,802,275 2014 3,826,263 6,082,893 9,173,947 14,556,687 16,843,128 17,487,722 17,806,537 2015 6,263,796 11,151,955 14,978,639 17,700,688 20,148,880 21,502,400 2016 7,435,120 12,009,273 15,916,432 21,438,785 23,326,143 2017 6,405,641 11,503,228 15,289,400 18,869,369 2018 4,959,689 9,254,754 12,129,118 2019 4,292,275 7,603,418 2020 6,004,292 (1) The information for the years 2011 through 2019 is presented as unaudited required supplementary information.
Average Annual Percentage Payout of Incurred Cliams (Tables)	The following table presents average annual percentage payout of incurred claims by age, net of reinsurance, as of December 31, 2020: Years 1 2 3 4 5 6 7 8 9 10 26.6 % 18.8 % 14.9 % 15.8 % 8.3 % 3.3 % 1.9 % 0.7 % 0.4 % 0.4 %

Restricted Funds (Details)

Restricted Funds (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Premium trust funds	$ 1,595,135	$ 1,758,915
Assigned to state agencies	710,000	710,000
Security pledged as collateral	787,653	0
Total restricted funds	$ 3,092,788	$ 2,468,915

Restricted Funds (Details Narra

Restricted Funds (Details Narrative) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Statutory Deposit Assigned to California State Treasurer	$ 510,000	$ 510,000
Statutory Deposit Held by Insurance Commissioner of State of Nevada	$ 200,000	$ 200,000

Concentration of Risks (Narrati

Concentration of Risks (Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
[CrusaderInsuranceCompany]
Premium written in California_percent of total	99.90%	99.90%
[HealthInsuranceProgramCommissionIncome]
Guardian Life Ins Co of America, percent of total	30.00%	39.00%
Blue Shield Care Trust, percent of total	56.00%	49.00%
Commission income from health insurance program	$ 727,515	$ 939,689

Concentration of Risks - By Rei

Concentration of Risks - By Reinsurer (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
[ReinsuranceRecoverables]	$ 22,874,949	$ 15,411,696
Renaissance Reinsurance U.S., Inc.
[ReinsuranceRecoverables]	11,906,416	8,095,647
Hannover Rusk SE
[ReinsuranceRecoverables]	10,673,173	6,869,914
TOA Re
[ReinsuranceRecoverables]	$ 295,188	438,308
Other
[ReinsuranceRecoverables]		$ 7,827

Cash and Cash Equivalents (Deta

Cash and Cash Equivalents (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Cash	$ 3,383,048	$ 2,490,902
Cash equivalents	574,932	3,290,737
Cash and cash equivalents	$ 3,957,980	$ 5,781,639

Investments - Investment Income

Investments - Investment Income and Net Realized Gains (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Investment income from fixed maturities	$ 2,068,592	$ 2,162,142
Investment income from equity securities	28,727	0
Investment income from short-term investments	24,603	65,642
Total investment income	2,121,922	2,227,784
Investment expense	133,679	129,842
Investment income net of expenses	1,988,243	2,097,942
Net realized investment gains (losses)	97,771	(12,661)
Net unrealized investment gains on equity securities	198,266	0
Investment income and net realized gains	$ 2,284,280	$ 2,085,281

Investments - Maturity (Details

Investments - Maturity (Details)	Dec. 31, 2020USD ($)
Investments - Maturity
Due in one year or less - Amortized Cost	$ 11,064,202
Due in one year or less - Estimated Fair Value	11,169,232
Due in one to five years - Amortized Cost	30,090,910
Due in one to five years - Estimated Fair Value	31,260,694
Due in five to ten years - Amortized Cost	18,476,051
Due in five to ten years - Estimated Fair Falue	19,806,444
Due after ten years and beyond - Amortized Cost	21,238,117
Due after ten years and beyond - Estimated Fair Value	21,971,324
Fixed maturities, at amortized cost	80,869,280
Fixed maturities, at estimated fair value	$ 84,207,694

Investments - Fixed Maturities

Investments - Fixed Maturities by Categories (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Amortized cost, fixed maturities, available for sale	$ 80,071,280	$ 82,002,411
Estimated fair value, fixed maturities, available for sale	83,409,694	83,499,710
Amortized cost, fixed maturities, held to maturity	798,000	798,000
Estimated fair value, fixed maturities, held to maturity	798,000	798,000
Fixed maturities, at amortized cost	80,869,280
Fixed maturities, at estimated fair value	84,207,694
U.S. treasury securities
Amortized cost, fixed maturities, available for sale	10,596,808	15,105,795
Gross unrealized gains, fixed maturities, available for sale	235,373	130,564
Gross unrealized losses, fixed maturities, available for sale	0	1,027
Estimated fair value, fixed maturities, available for sale	10,832,181	15,235,332
Corporate securities
Amortized cost, fixed maturities, available for sale	44,159,926	41,953,378
Gross unrealized gains, fixed maturities, available for sale	2,347,826	1,076,012
Gross unrealized losses, fixed maturities, available for sale	55,847	57
Estimated fair value, fixed maturities, available for sale	46,451,905	43,029,333
Agency mortgage backed securities
Amortized cost, fixed maturities, available for sale	25,314,546	24,943,238
Gross unrealized gains, fixed maturities, available for sale	833,336	293,757
Gross unrealized losses, fixed maturities, available for sale	22,274	1,950
Estimated fair value, fixed maturities, available for sale	26,125,608	25,235,045
Certificates of deposit
Amortized cost, fixed maturities, held to maturity	798,000	798,000
Gross unrealized gains, fixed maturities, held to maturity	0	0
Gross unrealized losses, fixed maturities, held to maturity	0	0
Estimated fair value, fixed maturities, held to maturity	798,000	798,000
Total fixed maturities
Fixed maturities, at amortized cost	80,869,280	82,800,411
Gross unrealized gains, fixed maturities	3,416,535	1,500,333
Gross unrealized losses, fixed maturities	78,121	3,034
Fixed maturities, at estimated fair value	$ 84,207,694	$ 84,297,710

Investments - Unrealized apprec

Investments - Unrealized appreciation on investments (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Gross unrealized appreciation of fixed maturities	$ 3,416,535	$ 1,500,333
Gross unrealized (depreciation) of fixed maturities	(78,121)	(3,034)
Net unrealized appreciation (depreciation) on investments	3,338,414	1,497,299
Deferred federal tax expense (benefit)	(701,067)	(314,433)
Net unrealized appreciation (depreciation), net of deferred income taxes	$ 2,637,347	$ 1,182,866

Investments - Securities in Unr

Investments - Securities in Unrealized Loss Position (Details)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Fair value, less than 12 months	$ 6,048,661	$ 3,746,438
Fair value, 12 months or longer	0	1,002,031
Gross unrealized losses, less than 12 months	115,478	2,259
Gross unrealized losses, 12 months or longer	$ 0	$ 775
Number of securities in unrealized loss positions for less than 12 months	39	4
Number of securities in unrealized loss positions for 12 months or longer	0	1
U.S. treasury securities
Fair value, less than 12 months	$ 0	$ 1,996,562
Fair value, 12 months or longer	0	1,002,031
Gross unrealized losses, less than 12 months	0	253
Gross unrealized losses, 12 months or longer	$ 0	$ 775
Number of securities in unrealized loss positions for less than 12 months	0	1
Number of securities in unrealized loss positions for 12 months or longer	0	1
Corporate securities
Fair value, less than 12 months	$ 2,101,986	$ 999,818
Fair value, 12 months or longer	0	0
Gross unrealized losses, less than 12 months	55,847	56
Gross unrealized losses, 12 months or longer	$ 0	$ 0
Number of securities in unrealized loss positions for less than 12 months	2	1
Number of securities in unrealized loss positions for 12 months or longer	0	0
Agency mortgage backed securities
Fair value, less than 12 months	$ 3,223,329	$ 750,058
Fair value, 12 months or longer	0	0
Gross unrealized losses, less than 12 months	22,274	1,950
Gross unrealized losses, 12 months or longer	$ 0	$ 0
Number of securities in unrealized loss positions for less than 12 months	12	2
Number of securities in unrealized loss positions for 12 months or longer	0	0
Total fixed maturities
Fair value, less than 12 months	$ 5,325,315
Fair value, 12 months or longer	0
Gross unrealized losses, less than 12 months	78,121
Gross unrealized losses, 12 months or longer	$ 0
Number of securities in unrealized loss positions for less than 12 months	14
Number of securities in unrealized loss positions for 12 months or longer	0
Equity Securities [Member]
Fair value, less than 12 months	$ 723,346
Fair value, 12 months or longer	0
Gross unrealized losses, less than 12 months	37,357
Gross unrealized losses, 12 months or longer	$ 0
Number of securities in unrealized loss positions for less than 12 months	25
Number of securities in unrealized loss positions for 12 months or longer	0

Investments - Fixed Maturitie_2

Investments - Fixed Maturities Sold and Called (Details)	12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Notes to Financial Statements
Sold securities - number	15	3
Sold securities - amortized cost	$ 5,529,470	$ 2,997,098
Sold securities - realized gain (loss)	$ 52,053	$ (12,679)
Called securities - number	4	1
Called securities - amortized cost	$ 2,449,503	$ 999,982
Called securities - realized gain	$ 497	$ 18

Investments - Equity Securities

Investments - Equity Securities (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Equity securities, cost	$ 2,548,440	$ 0
Unrealized gain	198,266	0
Equity securities, at fair value	$ 2,746,706	$ 0

Investments - Certificates of D

Investments - Certificates of Deposit (Narrative) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Investments - Certificates Of Deposit
Certificates of deposit brokered	$ 598,000	$ 598,000

Investments - State Held Deposi

Investments - State Held Deposits (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Short-term investments held by state	$ 200,000	$ 200,000
Certificates of deposit held by states	200,000	200,000
State held deposits	$ 400,000	$ 400,000

Investments - Short term invesm

Investments - Short term invesmtments (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
U.S. treasury bills	$ 0	$ 1,996,815
Certificates of deposit	200,000	200,000
Total short-term investments	$ 200,000	$ 2,196,815

Fair Vaule of Financial Instrum

Fair Vaule of Financial Instruments - Fair Value of Invested Assets (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
U.S. treasury securities	$ 10,832,181	$ 15,235,332
Corporate securities	46,451,905	43,029,333
Agency mortgage-backed securities	26,125,608	25,235,045
Equity securities	2,746,706	0
Short-term investments	200,000	2,196,815
Total financial instruments	86,356,400	85,696,525
Level 1
U.S. treasury securities	10,832,181	15,235,332
Corporate securities	0	0
Agency mortgage-backed securities	0	0
Equity securities	2,746,706
Short-term investments	200,000	2,196,815
Total financial instruments	13,778,887	17,432,147
Level 2
U.S. treasury securities	0	0
Corporate securities	46,451,905	43,029,333
Agency mortgage-backed securities	26,125,608	25,235,045
Equity securities	0
Short-term investments	0	0
Total financial instruments	72,577,513	68,264,378
Level 3
U.S. treasury securities	0	0
Corporate securities	0	0
Agency mortgage-backed securities	0	0
Equity securities	0
Short-term investments	0	0
Total financial instruments	$ 0	$ 0

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Property And Equipment
Accumulated depreciation on real estate held for sale	$ (1,867,659)	$ 0
Real estate held for sale, gross	10,202,676	0
Real estate held for sale	8,335,017	0
Land	0	1,787,485
Office building and tenant improvements	0	8,411,541
Furniture, fixtures, equipment and other leasehold improvements	2,191,411	2,110,653
Computer software under development	467,275	459,899
Accumulated depreciation and amortization	(2,423,617)	(3,617,381)
Computer software under development	1,803,346	1,074,398
Net property and equipment	$ 2,038,415	$ 10,226,595

Property and Equipment (Narrati

Property and Equipment (Narrative)	12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Feb. 12, 2021USD ($)	Sep. 29, 2020USD ($)
Property And Equipment Depreciation Abstract
Real estate listing price				$ 12,999,000
Real estate selling price			$ 12,695,000
Depreciation and amortization on all property and equipment	$ 673,895	$ 565,876
Square footage of Calabasas office building	46,884
Square footage of Calabasas office building leased to non-affiliated tenants	6,942
Square footage vacant in Calabasas office building	7,539
Office building revenue from leases to non-affiliated tenants	$ 150,319	177,596
Office building expenses including depreciation	$ 677,930	$ 669,359

Premiums, Commissions and Notes

Premiums, Commissions and Notes Receiveable (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Premium and commission receivable	$ 2,476,679	$ 2,178,476
Premium finance notes receivable	2,036,960	3,041,931
Total premium and notes receivable	4,513,639	5,220,407
Allowance for doubtful accounts	(1,192,302)	(1,200,970)
Net Receivables	$ 3,321,337	$ 4,019,437

Allowance for Doubful Account (

Allowance for Doubful Account (Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Notes to Financial Statements
Bad debt expense (benefit)	$ 6,450	$ 7,881

Losses and Loss Adjustment Expe

Losses and Loss Adjustment Expenses Reserves (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Losses And Loss Adjustment Expenses Reserves
Gross Case Reserves	$ 26,363,695	$ 23,663,743
Gross IBNR Reserves	48,529,814	31,402,737
Total Gross Reserves	74,893,509	55,066,480
Reserves Net Of Reinsurance
Net Case Reserves	21,027,703	18,128,008
Net IBNR Reserves	31,612,164	22,212,617
Total Net Reserves	52,639,867	40,340,625
Commercial Multi-Peril ($)	73,545,181	54,270,633
Other Liability ($)	1,283,174	776,957
Other Lines ($)	65,154	18,890
Total Direct Reserves By Line	$ 74,893,509	$ 55,066,480
Commercial Multi-Peril Percent of Total	9820.00%	9860.00%
Other Liability Percent of Total	170.00%	140.00%
Other Lines Percent Of Total	10.00%	0.00%

Losses and Loss Adjustment Ex_2

Losses and Loss Adjustment Expense Reserves - Rollforward (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Insurance Loss Reserves [Abstract]
Gross reserves	$ 74,893,509	$ 55,066,480	$ 51,657,155
Reinsurance recoverable on unpaid losses and loss adjustment expenses	22,253,642	14,725,855
Net reserves	52,639,867	40,340,625
Incurred losses and loss adjustment expenses
Current accident year	26,683,872	19,384,942
Prior accident years	7,959,048	3,191,185
Incurred losses and loss adjustment expenses	34,642,920	22,576,127
Paid losses and loss adjustment expenses
Current accident year	8,285,021	6,210,475
Prior accident years	14,058,657	18,150,580
Total payment losses and loss adjustment expenses	$ 22,343,678	$ 24,361,055

Losses And Loss Adjustment Ex_3

Losses And Loss Adjustment Expense Reserves - Incurred and Paid Claims (Details)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2012USD ($)	Dec. 31, 2011USD ($)
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 218,410,701	$ 203,000,161
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	31,604,666
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	167,214,395	164,132,073
Short-duration Insurance Contracts, Accident Year 2011
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	19,150,281	19,156,281	$ 19,094,732	$ 19,187,240	$ 18,224,634	$ 17,879,595	$ 17,014,895	$ 17,605,460	$ 17,900,250	$ 18,120,563
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 0
Cumulative number of reported claims	1,020
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 19,150,278	19,133,302	19,087,866	19,027,232	17,422,583	16,115,802	14,251,525	11,212,490	8,608,287	$ 4,719,943
Short-duration Insurance Contracts, Accident Year 2012
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	18,327,346	18,355,031	18,235,335	17,914,837	18,050,131	18,344,175	18,895,666	19,532,022	18,511,598
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 222
Cumulative number of reported claims	967
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 18,020,565	18,001,581	17,638,646	17,265,513	16,734,967	15,369,629	13,411,125	11,673,621	$ 6,719,982
Short-duration Insurance Contracts, Accident Year 2013
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	22,802,931	22,859,132	22,397,394	22,798,398	21,742,580	20,323,841	20,118,343	19,570,946
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 2
Cumulative number of reported claims	849
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 22,802,275	22,364,215	21,875,978	21,415,490	19,067,334	14,319,057	10,656,777	$ 7,594,731
Short-duration Insurance Contracts, Accident Year 2014
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	18,048,285	17,898,306	18,034,749	17,640,211	14,930,960	15,394,995	16,884,731
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 150,672
Cumulative number of reported claims	760
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 17,806,537	17,487,722	16,843,128	14,556,687	9,173,947	6,082,893	$ 3,826,263
Short-duration Insurance Contracts, Accident Year 2015
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	24,495,614	23,006,844	21,707,615	22,471,512	20,840,034	20,452,199
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 635,716
Cumulative number of reported claims	749
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 21,502,400	20,148,880	17,700,688	14,978,639	11,151,955	$ 6,263,796
Short-duration Insurance Contracts, Accident Year 2016
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	26,337,621	25,677,378	24,126,775	22,908,016	21,646,663
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 1,565,938
Cumulative number of reported claims	803
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 23,326,143	21,438,785	15,916,432	12,009,273	$ 7,435,120
Short-duration Insurance Contracts, Accident Year 2017
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	25,091,934	23,876,588	23,453,130	21,914,736
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 3,060,474
Cumulative number of reported claims	807
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 18,869,369	15,289,400	11,503,228	$ 6,405,641
Short-duration Insurance Contracts, Accident Year 2018
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	20,670,880	18,099,500	19,048,233
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 6,146,217
Cumulative number of reported claims	605
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 12,129,118	9,254,754	$ 4,959,689
Short-duration Insurance Contracts, Accident Year 2019
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	19,182,851	17,349,941
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 7,134,966
Cumulative number of reported claims	639
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 7,603,418	$ 4,292,275
Short-duration Insurance Contracts, Accident Year 2020
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	24,302,958
Total of Incurred But Not Reported Liabilities Plus Expected Development on Reported Claims	$ 12,910,459
Cumulative number of reported claims	699
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 6,004,292

Losses And Loss Adjustment Ex_4

Losses And Loss Adjustment Expense Reserves - Reconciliation of Incurred and Paid Claims to Unpaid Losses and LAE (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Insurance [Abstract]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 218,410,701	$ 203,000,161
Less: Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	167,214,395	164,132,073
Unpaid Losses and ALAE for Last Ten Accident Years	51,196,306	38,868,088
Unpaid Losses and ALAE Prior to Last Ten Accident Years	79,703	126,042
Unpaid Unallocated Loss Adjustment Expenses	1,363,858	1,346,495
Net reserves	52,639,867	40,340,625
Reinsurance recoverable on unpaid claims	22,253,642	14,725,855
Total gross loss and loss adjustment expense reserves	$ 74,893,509	$ 55,066,480

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Deferred Policy Acquisition Costs Disclosures [Abstract]
Balance	$ 3,619,594	$ 3,489,728
Acquisition costs deferred	4,782,461	5,090,712
Amortization	(4,898,807)	(4,960,846)
Premium deficiency reserve	$ 150,000	$ 0	$ 0

Accrued Expenses and Other Liab

Accrued Expenses and Other Liabilites (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Accrued Expenses And Other Liabilites
Premium payable	$ 393,466	$ 480,078
Unearned policy fee income	454,883	520,064
Retirement plan contributions payable	145,473	112,827
Salaries and employee beneifits payable	973,504	501,414
Commission payable	869	1,764
Security deposit for Calabasas building sale	380,850	0
Other	1,228,405	514,153
Accrued expenses and other liabilities	$ 3,577,450	$ 2,130,300

Reinsurance - Excess of Loss Re

Reinsurance - Excess of Loss Reinssurance Agreement (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
First layer participation percentage	0.00%	0.00%
First layer lower limit	$ 500,000	$ 500,000
First layer upper limit	$ 1,000,000	$ 1,000,000
Second layer participation percentage	0.00%	0.00%
Second layer lower limit	$ 1,000,000	$ 1,000,000
Second layer upper limit	$ 4,000,000	$ 4,000,000
Clash participation	0.00%	0.00%
Renaissance Reinsurance U.S., Inc.
A.M. Best Rating	A+	A+
Combined Retention (All Reinsurers)	$ 500,000	$ 500,000
Hannover Ruck SE
A.M. Best Rating	A+	A+
Combined Retention (All Reinsurers)	$ 500,000	$ 500,000

Reinsurance - Catastrophe Reins

Reinsurance - Catastrophe Reinssurance Agreement (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Reinsurance - Catastrophe Reinssurance Agreement
First layer participation percentage
First layer lower limit	$ 1,000,000	$ 1,000,000
First layer upper limit	$ 10,000,000	$ 10,000,000
Second layer participation percentage	0.00%	0.00%
Second layer lower limit	$ 10,000,000	$ 10,000,000
Second layer upper limit	$ 46,000,000	$ 46,000,000

Reinsurance - Effect Of Reinsur

Reinsurance - Effect Of Reinsurance (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Premiums written
Direct written	$ 36,338,800	$ 35,803,950
Reinsurance assumed	304,030	0
Reinsurance ceded	(8,078,748)	(7,153,130)
Net written	28,564,082	28,650,820
Premiums earned
Direct earned	36,108,230	33,958,202
Reinsurance assumed premiums	156,639	0
Reinsurance ceded premiums	(8,096,701)	(7,220,734)
Net premium earned	28,168,168	26,737,468
Loss And Loss Adjustment Expenses
Direct incurred loss and loss adjustment expenses	48,971,172	36,712,252
Assumed loss and loss adjustment expenses	89,204	0
Ceded loss and loss adjustment expenses	(14,417,456)	(14,136,125)
Incurred losses and loss adjustment expenses	$ 34,642,920	$ 22,576,127
Percent of ceded earned premium to direct earned premium	22.00%	21.00%

Profit Sharing Plan Expenses (D

Profit Sharing Plan Expenses (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Property Insurance Product Line, WAIC Automobile [Member]
Profit sharing plan expenses	$ 154,331	$ 138,670
Mandatory plan contribution percentage	3.00%	3.00%

Statutory Balances And Accounti

Statutory Balances And Accounting Practices (Schedule Of Statutory Net Income And Capital And Surplus) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statutory Balances And Accounting Practices Schedule Of Statutory Net Income And Capital And Surplus
Statutory net loss	$ (12,862,588)	$ (2,190,703)
Statutory capital and surplus	26,893,515	46,498,960
Intercompany dividend	4,000,000	$ 2,000,000
Maximum 2021 allowable dividend without prior Department of Insurance approval	$ 2,689,351
Adjusted capital to authorized control level risk based capital	278.00%
Authorized control level risk based capital	200.00%

Stock Plans - Stock Option Acti

Stock Plans - Stock Option Activity (Details) (USD$) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2017	Dec. 31, 2012	Dec. 31, 2011
Number of shares outstanding - roll forward
Outstanding	0	0
Granted under 2011 Incentive Stock Plan	0	0		8,760	91,240
Forfeited or expired			100,000
Incentive stock plan shares authorized under 2011 Incentive Stock Plan					200,000

Income Taxes (Components Of Inc

Income Taxes (Components Of Income Tax Expense) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]
Current, Federal	$ 0	$ 13,809
Deferred, Federal	3,566,840	(51,809)
Federal, Total	3,566,840	(38,000)
Current, State	8,800	8,800
Deferred, State	(28,042)	(104,987)
State, Total	(19,242)	(96,187)
Total, Current	8,800	22,609
Total, Deferred	3,538,798	(156,796)
Total	$ 3,547,598	$ (134,187)

Income Taxes (Reconciliation Of

Income Taxes (Reconciliation Of Income Taxes) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]
Computed tax expense	$ (3,768,138)	$ (682,477)
State tax expense (benefit)	(572,511)	(139,765)
Change in valuation allowance - state	557,310	63,777
Change in valuation allowance - federal	7,319,959	600,000
Deferred tax true up	58	289
Other	10,920	23,989
Total	$ 3,547,598	$ (134,187)
Federal tax rate	21.00%	21.00%

Deferred Tax Assets And Liabili

Deferred Tax Assets And Liabilities (Details) (USD $) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Deferred tax assets
Discounting of loss reserves	$ 531,845	$ 329,065
Net unearned premium	759,659	747,217
Unearned Commission	438,574	432,969
Unearned policy fees	127,293	145,533
Net operating loss caryforwards	7,769,603	4,145,783
State income taxes	2,402,438	1,931,665
Unrealized losses on investments	0	0
Bad debt reserve	333,649	336,075
Other deferred tax assets	237,803	205,292
Total deferred tax assets	12,600,864	8,273,599
Valuation allowance	10,557,080	2,531,665
Deferred tax assets net of valuation allowance	2,043,784	5,741,934
Deferred tax liabilities
Policy acquisition costs	858,705	892,349
State tax on undistributed insurance company earnings	84,219	343,735
Federal tax liability on state deferred tax assets	91,277	90,461
Depreciation	266,880	175,524
Unrealized gains on investments	742,703	314,433
Total deferred tax liabilities	2,043,784	1,816,502
Net deferred tax assets	$ 0	$ 3,925,432

Deterred Tax Assets (Narrative)

Deterred Tax Assets (Narrative) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Deterred Tax Assets
Deferred tax asset	$ 7,769,603
Federal net operating loss caryforwards beginning to expire in 2035	36,998,110
State tax loss carryforwards expiring between 2028 and 2040	2,402,438
Deferred tax asset valuation allowance on federal tax loss carryforward	$ 10,557,080	$ 600,000
Federal effected state tax rate	6.98%
Deferred tax asset valuation allowance on state tax loss carryforward		$ 1,931,665

Repurchase of Common Stock (Det

Repurchase of Common Stock (Details)	12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Aug. 10, 2020USD ($)
Notes to Financial Statements
Number of shares repurchased, 2020 program	857	0
Cost of shares repurchased allocated to retained earnings, 2020 program	$ 4,071	$ 0
Cost of shares repurchased allocated to capital, 2020 program	422	0
Cost of shares repurchased, total, 2020 program	$ 4,493	$ 0
Number of shares repurchased, 2008 program	978	383
Cost of shares repurchased allocated to retained earnings, 2008 program	$ 5,760	$ 2,108
Cost of shares repurchased allocated to capital, 2008 program	480	188
Cost of shares repurchased, total, 2008 program	6,240	$ 2,296
Dollar amount authorized under 2020 program			$ 5,000,000
Dollar amount available under 2020 program	$ 4,995,507

Related Party Transactions (Det

Related Party Transactions (Details)	12 Months Ended
	Dec. 31, 2020USD ($)shares	Dec. 31, 2019USD ($)
Notes to Financial Statements
Square footage of office building leased to related party		4,189
Monthly lease payment		$ 8,378
Consulting services contracted amount	$ 20,000
Consulting services paid amount | shares	15,000

Earnings Per Share (Details)

Earnings Per Share (Details)	3 Months Ended								12 Months Ended
	Dec. 31, 2020USD ($)$ / shares	Sep. 30, 2020USD ($)$ / shares	Jun. 30, 2020USD ($)$ / shares	Mar. 31, 2020USD ($)$ / shares	Dec. 31, 2019USD ($)$ / shares	Sep. 30, 2019USD ($)$ / shares	Jun. 30, 2019USD ($)$ / shares	Mar. 31, 2019USD ($)$ / shares	Dec. 31, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares
Notes to Financial Statements
Loss per share - diluted | $ / shares	$ (0.39)	$ (3.38)	$ (0.08)	$ (0.20)	$ (0.45)	$ 0.04	$ (0.05)	$ (0.13)	$ (4.05)	$ (0.59)
Loss per share - basic | $ / shares	$ (0.39)	$ (3.38)	$ (0.08)	$ (0.20)	$ (0.45)	$ 0.04	$ (0.05)	$ (0.13)	$ (4.05)	$ (0.59)
Net loss | $	$ (2,071,985)	$ (17,940,488)	$ (434,814)	$ (1,043,826)	$ (2,380,419)	$ 212,467	$ (276,677)	$ (671,074)	$ (21,491,113)	$ (3,115,703)
Effect of diluted securities									0	0
Weighted average shares outstanding - diluted									5,305,829	5,306,879
Weighted average shares outstanding - basic									5,305,829	5,306,879
Common share equivalents excluded from diluted shares									0	0

Subsequent Events (Details)

Subsequent Events (Details)	Feb. 12, 2021USD ($)shares
Subsequent Events [Abstract]
Building selling price	$ 12,695,000
Gain on building sale	$ 4,359,982
Building selling costs | shares	666,124
Office lease term, months	12
Monthly office lease rent	$ 52,637

Quarterly Financial Information

Quarterly Financial Information (Summary Of Quarterly Financial Information) (Details) (USD $) - USD ($)	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Quarterly Financial Information Summary Of Quarterly Financial Information Details
Total Revenues	$ 8,319,017	$ 8,259,686	$ 7,976,227	$ 8,005,181	$ 8,183,276	$ 8,258,966	$ 7,795,098	$ 7,135,474	$ 32,560,111	$ 31,372,814
Income (Loss) Before Taxes	(2,067,539)	(14,345,916)	(384,562)	(1,145,498)	(2,426,214)	330,726	(342,670)	(811,732)
Net Income (Loss)	$ (2,071,985)	$ (17,940,488)	$ (434,814)	$ (1,043,826)	$ (2,380,419)	$ 212,467	$ (276,677)	$ (671,074)	$ (21,491,113)	$ (3,115,703)
Basic
Basic Earnings (Loss) Per Share	$ (0.39)	$ (3.38)	$ (0.08)	$ (0.20)	$ (0.45)	$ 0.04	$ (0.05)	$ (0.13)	$ (4.05)	$ (0.59)
Diluted
Diluted Earnings (Loss) Per Share	$ (0.39)	$ (3.38)	$ (0.08)	$ (0.20)	$ (0.45)	$ 0.04	$ (0.05)	$ (0.13)	$ (4.05)	$ (0.59)

Supplementary Information on _3

Supplementary Information on Loss and ALAE Development - Incurred and Paid Claims (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 218,410,701	$ 203,000,161
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	167,214,395	164,132,073
Short-duration Insurance Contracts, Accident Year 2011
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	19,150,281	19,156,281	$ 19,094,732	$ 19,187,240	$ 18,224,634	$ 17,879,595	$ 17,014,895	$ 17,605,460	$ 17,900,250	$ 18,120,563
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	19,150,278	19,133,302	19,087,866	19,027,232	17,422,583	16,115,802	14,251,525	11,212,490	8,608,287	$ 4,719,943
Short-duration Insurance Contracts, Accident Year 2012
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	18,327,346	18,355,031	18,235,335	17,914,837	18,050,131	18,344,175	18,895,666	19,532,022	18,511,598
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	18,020,565	18,001,581	17,638,646	17,265,513	16,734,967	15,369,629	13,411,125	11,673,621	$ 6,719,982
Short-duration Insurance Contracts, Accident Year 2013
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	22,802,931	22,859,132	22,397,394	22,798,398	21,742,580	20,323,841	20,118,343	19,570,946
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	22,802,275	22,364,215	21,875,978	21,415,490	19,067,334	14,319,057	10,656,777	$ 7,594,731
Short-duration Insurance Contracts, Accident Year 2014
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	18,048,285	17,898,306	18,034,749	17,640,211	14,930,960	15,394,995	16,884,731
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	17,806,537	17,487,722	16,843,128	14,556,687	9,173,947	6,082,893	$ 3,826,263
Short-duration Insurance Contracts, Accident Year 2015
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	24,495,614	23,006,844	21,707,615	22,471,512	20,840,034	20,452,199
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	21,502,400	20,148,880	17,700,688	14,978,639	11,151,955	$ 6,263,796
Short-duration Insurance Contracts, Accident Year 2016
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	26,337,621	25,677,378	24,126,775	22,908,016	21,646,663
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	23,326,143	21,438,785	15,916,432	12,009,273	$ 7,435,120
Short-duration Insurance Contracts, Accident Year 2017
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	25,091,934	23,876,588	23,453,130	21,914,736
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	18,869,369	15,289,400	11,503,228	$ 6,405,641
Short-duration Insurance Contracts, Accident Year 2018
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	20,670,880	18,099,500	19,048,233
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	12,129,118	9,254,754	$ 4,959,689
Short-duration Insurance Contracts, Accident Year 2019
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	19,182,851	17,349,941
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	7,603,418	$ 4,292,275
Short-duration Insurance Contracts, Accident Year 2020
Claims Development [Line Items]
Cumulative Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	24,302,958
Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance	$ 6,004,292

Supplementary Information - Ave

Supplementary Information - Average Annual Percentage Payout of Incurred Claims by Age (Details)	Dec. 31, 2020
Insurance [Abstract]
Short-duration insurance contracts, historical claims duration, year one	26.60%
Short-duration insurance contracts, historical claims duration, year two	18.80%
Short-duration insurance contracts, historical claims duration, year three	14.90%
Short-duration insurance contracts, historical claims duration, year four	15.80%
Short-duration insurance contracts, historical claims duration, year five	8.30%
Short-duration insurance contracts, historical claims duration, year six	3.30%
Short-duration insurance contracts, historical claims duration, year seven	1.90%
Short-duration insurance contracts, historical claims duration, year eight	0.70%
Short-duration insurance contracts, historical claims duration, year nine	0.40%
Short-duration insurance contracts, historical claims duration, year ten	0.40%

Uncategorized Items - unam-2020

Label	Element	Value
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net	us-gaap_DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired	$ 3,503,248